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Fahim Mohammad

ABSTRACT

A SYSTEMS-BASED APPROACH FOR DETECTING MOLECULAR INTERACTIONS
ACROSS TISSUES

Fahim Mohammad
June 18, 2012

Current high-throughput gene expression experiments have a straightforward design of examining
the gene expression of one group or condition relative to that of another. The data is typically
analyzed as if they represent strictly intracellular events, and often treats genes as coming from a
homogeneous population. Although intracellular events are crucial to nearly all biological processes,
cell-cell interactions are often just as important, especially when gene expression data is generated
from heterogeneous cell populations, such as from whole tissues. Cell-cell molecular interactions are
generally lost in the available analytical procedures and as a result, are not examined experimentally,
at least not accurately or with efficiency. Most importantly, this imposes major limitations when
studying gene expression changes in multiple samples that interact with one another.

In order to addresses the limitations of current techniques, we have developed a novel systems-based approach that expands the traditional analysis of gene expression in two stages. This includes
a novel sequence-based meta-analytic tool, A bsIDconvert, that allows for conversion of annotated
features using an interval tree for storing and querying absolute genomic coordinates for comparison
of multi-scale macro-molecule identifiers across platforms and/or organisms.

In addition, a systems-based heuristic algorithm is developed to find intercellular interactions
between two sets of genes, potentially from different tissues by utilizing location information of each
gene along with the information available in the secondary databases in the form of interactions,
pathways and signaling.
vii

AbsIDconvert is shown to provide a high accuracy in identifier conversion as compared to other
available methodologies (typically at an average rate of 84%) while maintaining a higher efficiency
(O(n

* log(n)).

Our intercellular interaction approach and underlying visualization shows promise

in allowing researchers to uncover novel signaling pathways in an intercellular fashion that to this
point has not been possible.
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CHAPTER 1
INTRODUCTION

1.1

Current trends in high-throughput gene expression analysis

Typical high-throughput experiments have a straightforward design of examining the gene expression
of one group/condition relative to that of other group such as control vs treated or healthy vs
diseased. Advancement and sophistication in the primary and secondary analytical tools have made
these analysis reliable, accurate and rapid and have enabled the user to extract greater meaning
from large datasets in the form of statistically over-represented signaling pathways, genes following
similar expression patterns, and clustering and classification of samples and/or genes. However,
analytical tools currently employed generally examine the data as if they represent strongly intracellular events, and often treat them as coming from a homogeneous cell population.

1.2

Motivation

Although intracellular events are crucial to nearly all biological processes, cell-cell interactions are
often just as important, especially when gene expression data is generated from a heterogeneous
cell population, such as from whole tissue. Cell-cell interactions are generally lost in the available
analytical procedures and as a result, are not examined experimentally, at least not accurately or
with efficiency. Most importantly, this imposes major limitations when studying gene expression
changes in multiple samples that interact with one another. Examples of such interactions include
migratory processes (e.g., immune cell transvascular migration, nervous system development, and
cancer metastasis), binding processes (e.g., oocyte implantation and leukocyte tethering and rolling)
induction processes (e.g., stem cell generation and floor-plate or roof-plate modulation of neuronal

1

2. A heuristic algorithm that generates interaction paths between two sets of genes. Considering these two sets of genes possibly from two tissues as seeds and using protein interaction
information available in publicly available databases, this algorithm finds all interacting genes
between two tissues. While finding interactions, it also uses location information of involved
genes and removes any gene that is irrelevant in order to keep the final set of interactions
minimal.
Development of this approach is driven by a specific problem in neurobiology, namely identification of the genes regulating the neuronal plasticity process of axonal collateral sprouting (where
existing intact axons extend new branches and functional connections). It is known that the process
of collateral sprouting (CS) involves significant interaction between the neuron undergoing plasticity
and the target tissue which is generally other neurons or a peripheral tissue (i.e. involves intercellular, inter-tissue interactions). Therefore gene expression datasets are generated by Dr. leff

Petruska's Lab for sensory neurons undergoing CS, their peripheral target tissue (skin), and their
nervous system target tissue (spinal cord). The genetic control of this process is coordinated across
multiple interacting tissues. Current molecular informatics tools fall far short of allowing an efficient
analysis of this interplay and uncovering the many signaling aspects that control this process. Although the tool is developed in the framework of the model of CS, the analysis is readily applicable
to any experimental design in which a separation can be achieved for two or more interacting tissues,
cell populations or potentially host-pathogen relationships.
The overview of chapters 2 through 6 follows:
Chapter 2 briefly explains the relevant basic molecular biology. It also explains the Central
Dogma of Molecular Biology and the process of transcription and translation that are necessary for
every living organism. Recent advances in molecular biology techniques have resulted in a number of
high-throughput sequencing methods including next-generation sequencing and microarrays. These
sequencing tools are capable of sequencing the complete genome of living organisms. This thesis work
uses data generated from these technologies which are briefly explained. Genomes and sequencing
approaches are discussed in sections 2.2 and 2.3. Genome assembly, alignments, annotations and

3

annotation databases are covered in separate sections. Microarrays are briefly discussed in section
2.7.
Chapter 3 explains the algorithms used in the construction of AbsIDconvert. The 2012 database
issue of Nucleic Acid Research reports a total of 1380 databases covering various areas of molecular
biology [2].

Most of these databases are independent of each other and annotate genetic enti-

ties differently. This large collection of heterogeneous datasets results in issues with the storage
and comparison of annotations across entities. This chapter focuses on this concern and proposes
an interval-tree as an efficient means for the storage, search and maintenance of genetic entities.
Section 3.1 introduces to the problem and describes how these annotations can be represented as
intervals. Section 3.2 discusses intervals and the criteria for detecting overlapping intervals in a
system with multiple intervals. Section 3.3 describes interval-trees, a data structure to store annotations (as intervals) and perform associated operations. Section 3.4 describes the design steps
in finding overlapping annotations. It also briefly describes two alignment algorithms, which will
be used later in our approach to map sequences onto a reference genome. Results are shown in
section 3.5. Finally, section 3.6 concludes this chapter.
Chapter 4 describes AbsIDconvert, a tool for comparing multi-scale macromolecule identifiers
across platforms/organisms/labs to allow for powerful meta-analyses. Meta-annotations are extremely dynamic and change on a daily basis.

Rather than relying on different meta-analysis

databases, AbsIDconvert is constructed for mapping between various annotation granularities at
the locus, transcript, sequence, and probe level. The key to this novel system is to reduce each
identifiers to the sequence level which is common between all annotations. For organisms with a
reference genome available, each annotation can be aligned to the respective genome and given absolute coordinates. Depending on the alignment positions on the genome, interval information for
each identifier is found and maintained in an interval tree. These interval trees can then be queried
to find all overlapping identifiers for a particular identifier. AbsIDconvert has many potential uses,
including gene identifier conversion and cross-species comparisons. AbsIDconvert provides an efficient, accurate and reliable mechanism for conversion between two identifier domains of interest.

4

The flexibility of AbsIDconvert will allow for these identifier domains to be custom defined as long
as a genomic mapping interval can be determined.
This chapter discusses all aspects of AbsIDconvert. Section 4.1 introduces the problem of identifier (ID) conversion, associated problems and challenges. Section 4.2 describes the available methods
and tools to perform ID conversion. The next section 4.3 describes the drawbacks associated with
the available tools. Section 4.4 describes the AbsIDconvert approach for performing ID conversion. System design and implementation is discussed in section 4.5. Section 4.6 reports the results
and includes run time and output comparison of AbsIDconvert with a number of available tools.
Section 4.7 details three case studies to show the applicability of AbsIDconvert which is otherwise
difficult. Section 4.8 concludes this chapter.
As mentioned previously, cell-cell interactions are as important as intracellular interactions when
gene expression data is generated from a heterogeneous cell population, such as from whole tissue.
Chapter 5 discusses a heuristic algorithm for detecting intercellular interactions from two sets of
genes. The heterogeneous gene sets can be preprocessed using AbsIDconvert to make the data
compatible for comparison. Section 5.1 introduces the actual problem of detecting intercellular
interactions.

Section 5.2 lists and explains some of the available protein interaction databases.

Section 5.3 briefly introduces some of the available algorithms to find intercellular interactions.
Section 5.4 discuss the methodology and design. Section 5.5 analyses the fitness and completeness
of the algorithm. Section 5.6 reports the results. Section 5.7 concludes this chapter.
Chapter 6 is dedicated to summary and future work.
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CHAPTER 2
BACKGROUND

2.1
2.1.1

Basic molecular biology
Organism and cells

All living organisms are composed of small cells, often too small to be seen by a naked eye. These cells
are the basic structural and functional unit of all known organisms and often termed as the building
block of life. A typical cell size ranges from 1 Jim in bacteria to 100 Jim in plant. The estimated
number of cells in the human body is more than 60 trillion and there are roughly 320 different
cell types [3]. Organisms may be categorized as unicellular or multicellular based on whether they
are composed of a single or multiple cells. Another categorization may be based on the presence
or absence of a nucleus in their cells. Prokaryotes lack a nucleus and their DNA (explained later)
floats loosely in the liquid center of the cell (Fig. 2.1). Prokaryotic organisms were the only form
of life millions of years ago, and they gradually evolved into complex organisms. Prokaryotes are
unicellular organisms while eukaryotes are composed of both unicellular and multicellular organisms
with a well-defined nucleus to house their DNA.

2.1.2

Chromosomes

A chromosome is a thread like structure with a single piece of coiled DNA. It may contain proteins,
which serve to package the DNA and control their functions. Prokaryotes have a single circular hoopshaped DNA whereas eukaryotes have one or more chromosomes housed in the nucleus. Eukaryotic
chromosomes are long strands of DNA tightly wound around proteins into a condensed structure
called chromatin.

In humans, there are 22 pairs of autosomal chromosomes and a pair of sex
6

Prokaryoti c cell

Eukaryoti c cell

Figure 2.1: P rokaryotic and eukaryotic cell [4]. Used with permission.

chromosomes. In each pair, one chromosome is inherited from father and the another from mother.
The sex chromosomes are X and Y determine the sex of a human being. Females have two X
chromosomes whereas males have an X and a Y chromosome [5] [6]. For organisms to grow, reproduce
and pass genetic infor mation, these chromosomes must be copied and divided in a regulated manner.

2.1.3

Molecules of life

There are four categories of molecules imp ortant for a life: small molecules, nucleic acids (DNA and
RNA) and proteins. DNA, RNA and proteins are collectively termed as biological macromolecules.
Small molecules are the building blocks for macromolecules and may be involved in functions such
as signal transmission, biochemical reactions and cellular processes. Examples include water , amino
acids, nucleotides , sugars and some fatty acids [4].

DNA
Every living organism on earth uses DeoxyriboNucleic Acid (DNA) to store and pass genetic information from one generation to the next . DNA is necessary for the development and functioning of
all living organisms. During the 1920s, P.A . Levene analyzed the components of the DNA molecule
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and concluded that DNA contains four nitrogenous bases: adenine(A) , guanine(G), cytosine(C) and
thymine(T); deoxyribose sugar; and a phosphate group [4]. These nitrogenous bases can be classified into two types: purines and pyrimidines. Purines have two fused rings with two nitrogen atoms
within each ring whereas purines have a single-ring structure with two nitrogen atoms within the
ring (Fig. 2.2).

Purines

Guanine
Pyrimidines

f:N~O "CNAo
0

NH

I

H

H

Cytosine

Thymine

0

CNH

NAo
H

Uracil

Figure 2.2: Chemical structure of the nucleotides.

In 1953, James D. Watson and Francis H. C. Crick at Cavendish Lab in Cambridge solved the
mystery of the structure of DNA by proposing a simple double helix model which earned them the
Nobel Prize in 1962 [8] [9]. DNA consists of two long polymers of nucleotides (polynucleotides) with
backbones made of sugars and phosphate groups joined by ester bonds (Fig: 2.3). These two polymers
which may be of any length and contain any sequence, run in opposite directions of each other and
are therefore anti-parallel. The opposite strands stick together via two hydrogen bonds between
A and T, and three hydrogen bonds between C and G, forming a ladder-like structure [9]. These
hydrogen bonds are individually weak but collectively quite strong that makes double helix DNA
stable [5]. The two ends of the strands are chemically different and thus, a 5' or 3' directionality
can be assigned to each polynucleotide based on the carbon atoms of the sugar molecule. The
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Thymine
Adenine
5'end o

3'end

~/
o

o
H:zN

0

y~

~a
'J',
H:zI!

o

'\./-

J-O

""'~

OH

3 ' end

C. ~
ytosme j
Guanine
5' end

Figure 2.3: Chemical structure of a DNA molecule [7]. Numbers in inset shows how the carbon
atoms are numbered in a sugar molecule. Used with permission.

polynumcleotide sequence in Fig. 2.3 is ACTG. The length of a DNA molecule is usually measured
in base-pairs (bp) or nucleotides (nt).
DNA replication is the basis for biological inheritance and is a mechanism in which one doublestranded DNA is replicated into two identical ones. The DNA double helix unwinds and forks during
this process, and a new complimentary strand is synthesized by specific molecular machinery on each
branch of the fork (Fig. 2.4) . This happens during cell division and a copy of the original goes to
the newly formed daughter cells [4] [11].

RNA
RiboNucleic Acid (RNA) is similar to DNA except that Thymine (T) is replaced by Uracil (U).
In addition, RNA nucleotides have the sugar ribose incorporated whereas DNA nucleotides use
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Figure 2.4: DNA replication [10]

deoxyribose. RNA molecules typically consist of a much shorter chain of nucleotides and are less
stable than DNA. RNA can be single stranded or double stranded, but is generally found in singlestrand form. Most biologically active RNAs , including mRNA , tRNA , rRNA, snRNAs and other
non-coding RNAs, contain self-complementary sequences that allow parts of the RNA to fold and
pair with itself to form double helices.

mRNA
Messenger RNA (mRNA) encodes genetic information transcribed from a DNA template into a
series of three-base codons, each of which specifies a particular amino acid with the exception of
stop codons, which terminate protein synthesis. The mRNA carries this genetic information into
the cytoplasm where protein synthesis occur.

m iRN A
MicroRNA (miRNA) are naturally occurring small (22 nt) non- coding RNA usually found in eukaryotic cells. MiRNA are post- transcriptional regulators and may bind to mRNA molecules resulting
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in downregulation of gene expression through translational repression, mRNA cleavage and deadenylation.

Proteins
Proteins, dubbed as workers in the cellular factory, are responsible for carrying out many functions
of the cell, including metabolism, transport, communication, structure and division. Proteins are
sometimes also touted as the "movers and shakers" of the cell- whatever is the job, they get it
done. They interact with other molecules to carry out their functions. Proteins begin as polymers
of amino acids, called polypeptides. A protein becomes functional when it is folded. The size of the
protein molecule can vary from a few to thousands of amino acids in length. For example, insulin is
a small protein with 51 amino acids whereas titin has ::::; 28,000 amino acids [4]. The shapes of the
proteins are complex and essential for function and may vary from primary structure to quaternary
structure such as hemoglobin proteins (Fig. 2.5) [11].

2.1.4

Central Dogma of Molecular Biology

"I just didn't know what dogma meant. And I could just as well have called it the
'Central Hypothesis', or ~- you know. Which is what I meant to say. Dogma was just a
catch phrase. [8j"

-Francis Crick

The Central Dogma of Molecular Biology explains information transfer from genotype to phenotype and states that, once an information (sequences) get into protein, it cannot get out again [13]. It
classifies a total of nine possible information transfers into three groups each containing three types
of transfers. General transfers are believed to take place in most cells and include DNA ---+ DNA
(replication), DNA ---+ RNA (transcription) and RNA ---+ protein (translation) transfers (Fig. 2.6).
DNA replication is a biological process in which a DNA molecule is copied. DNA transcription involves the transcribing of the genetic information from DNA to mRNA. In translation, the mRNA,
produced during transcription, is decoded by the ribosome to produce a specific amino acid chain,
that will later fold into an active protein. Special transfers are the cases which are known to occur
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Figure 2.5: Levels of protein structure [12]. Used with permission.

only under specific conditions. Examples include RNA -t RNA (RNA replication), RNA -t DNA
(Reverse transcription) and DNA -t protein. Reverse transcription is the information transfer from
RNA to DNA and are known to occur in the case of retroviruses such as HIV. Direct translation
from DNA to protein has been demonstrated in laboratory setup (in vitro) . The last group is un-

known transfers, which are not known to occur, includes protein -t protein, protein -t DNA and
protein -t RNA [14] transfers.

2.1.5

Gene

A gene is a fragment of genomic DNA that can be transcribed into an mRNA sequence that is
subsequently translated into a protein. It is a molecular unit of heredity of all living organisms
and holds information to build and maintain an organism 's cells and pass genetic traits to the next
12
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Figure 2.6: Central Dogma of Molecular Biology

generation. The total number of human genes was initially estimated to be around 100,000. The
draft genome sequence paper [15] published in Feb, 2001 estimated only about 30,000 to 40,000.
Although the exact number of human genes is still unknown, researchers estimate it to be fewer
than 30,000. In eukaryotic genomes, the coding portion of a gene, called exons, are interrupted
by intervening sequences, called introns. Both exons and introns are transcribed into pre-mRNA.
Promoters and enhancers determine what port ions of the DNA will be transcribed into the precursor
mRNA (pre-mRNA). The exons in the pre-rnRNA are spliced together to form a mature mRNA,
which is later translated into protein (Fig. 2.7) .

2.1.6

'franscription

Transcription is the process of creating a complementary RNA copy of a sequence of DNA. This
process is accomplished in three steps: initiation, elongation and termination. During initiation,
RNA polymerase binds at a sequence called a promoter. A typical promoter sequence in many
eukaryotes is TATA box as its sequence consists of TATAAA (Fig. 2.8).

A promoter tells the

RNA polymerase that the gene to transcribe is about 30 base pairs downstream. Transcription
is performed on the template strand and the resultant RNA is the transcript of the nontemplate
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strand. RNA polymerase along with other proteins, called transcription factors, opens up the DNA
double helix and start reading the template strand in a 3' to 5' direction. In elongation, the RNA
polymerase traverses the template strand and produces an RNA copy from 5' to 3' direction. This
RNA molecule is an exact copy of the nontemplate strand except that thymines replace by uracils.
In termination, the RNA polymerase encounters the terminator sequence and transcription stops at
this place. At this time, the mRNA gets detached from the template and the double--stranded DNA
molecule snaps back into its natural helical shape.

2.1.7

Post- transcription process

After being produced, the transcribed RNA (precursor mRNA or pre-mRNA) goes through some additional modification in eukaryotes including capping, polyadenylation and splicing. During capping,
a 5' cap is added to the mRNA that helps in ribosomal binding during translation. In polyadenyla-

tion, a long string of adenines are added to the 3' end of the pre-mRN A. This string is also sometimes
referred as poly- A tail. A poly- A tail increases the half-life of mRNA and also helps in increased
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translation. Splicing removes introns, the non coding region , from the pre-mRNA and stitches the
exons together without interruption. Once post- transcriptional processing is complete, the mRNA
migrates out of the cell nucleus, into the cytoplasm where it is translated into a protein.

Alternative splicing is a process through which exons in the pre-mRNA are spliced together
in multiple ways to form a mature mRNA. The resulting mRNA may be translated into different
protein isoforms; thus, a single gene may code for multiple proteins. Fig. 2.9 represents four common
types of alternative splicing. In type (a) , different promoters may be used for different splice variants
which result into mRNA transcripts having different start sites. Type (b) represents selection of
different poly- A sites that result in different 3' ends. An entire exon may be skipped in this process.
In the third type (c), introns may be retained in the final transcript. In type (d) , an entire exon or
a combination of exons may be skipped to form different transcripts.
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2.1.8

G en etic code

The genetic code is the set of rules by which information encoded in genetic material is translated
into amino acid sequences. The code defines a mapping between tri-nucleotide sequences, called
codons, and amino acids. There are 64 different codons that result in 20 amino acids, thus resulting
in degeneracy, with more than one triplet coding an amino acid. In. most cases, the first and second
base of the triplets coding for a particular amino acid remain same with the difference in the third
or wobble base. The start codon called methionine is coded by AUG. The stop codons are UAA ,
UAG, and UGA and do not encode any amino acid. The stretch of codons between AUG and a stop
codon is called an open reading frame (ORF) [17](Fig: 2.10).
Given an mRNA sequence, translation to the corresponding amino acid may start either at first ,
second or third base of an oligonucleotide. Considering a double-stranded DNA sequence, there are
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three translation start sites possible on each strand. Each of these frames may produce a completely
different amino acid sequence. An example of this conversion on one strand is shown in Fig. 2.11.
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Figure 2.11 : Thanslation of a single stranded mRNA into an amino acid sequence.

2.1.9

Translation

Once transported into the cytoplasm , an mRNA can be translated into a polypeptide using the
genetic code with the help of ribosomes, tRNA , rRNA and other components .
• Transfer RNA (tRNA) is an adapter molecule composed of RNA , typically 73 to 93 nucleotides

in length. These are produced by transcription but are never translated. It has a unique
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three dimensional structure and carries an amino acid molecule on one end and a three-letter
anticodon on the other end. Its job is to bring the amino acid molecule to the ribosome and
help in translation.

• In the cytoplasm, ribosomal RNA (rRNA) combines with proteins to form ribosomes, which
act as a site of protein synthesis.
• A ribosome is a large complex molecule which is responsible for catalyzing the formation of
proteins. Ribosomes are found in all living organisms. They are made up of two subunits:
large and small, which have their own rRNA, and are capable of constructing any sort of
protein. A ribosome has three binding sites; 1) A site, where tRNA inserts its anticodon arm
to match with codon of the mRNA molecule, 2) P site, where amino acids are attached using
peptide bonds and 3) E site, where tRNAs are released from the ribosome after their amino
acids become part of the growing polypeptide chain.
Translation proceeds in three steps: initiation, elongation and termination.

• The initiation starts with binding the small subunit of a ribosome to the 5' end of an mRNA.
This subunit proceeds downstream until it encounters the start codon where it is joined by the
large subunit. A tRNA with an anticodone sequence identical to the complementary mRNA
codon binds at the P site of the ribosome [18J.
• During elongation, the ribosome calls for the tRNA carrying the amino acid specified by the
codon residing in the A-site. An appropriate tRNA is able to base pair with the next codon
on the mRNA. The preceding amino acid bonds with the incoming amino acid via a peptide
bond. Once the bonding is complete, the ribosome shifts to the next codon on mRNA (this
shifting is called translocation). The initiator tRNA then moves to E site and is later released.
This process is repeated until all the co dons in the mRNA has been read by tRNA [19J.
• Once the ribosome reach a stop codon (VAA, VAG and VGA), no more amino acids can
be added. In place of tRNAs, another protein called release factors, bind to the ribosome.
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This binding initiates the cleavage of the polypeptide chain and release of the subunits of the
ribosome.

The polypeptides are then folded into one or more specific spatial conformations, driven by a
number of non-covalent interactions which then carry out a variety of biological functions.

2.1.10

Untranslated regions (UTR)

During translation, the regions those are not translated include the cap, the 5' UTR, 3' UTR and
poly- A tail (Fig. 2.12). Five-prime (5') UTRs may contain regulatory elements that can positively control gene expression. In prokaryotes, the 5' UTR usually contains a ribosome binding site
(RBS), also known as the Shine Dalgarno sequence (AGGAGGU). The median length of 5' UTR.s
is approximately 150 nt but may be as long as several thousand bases [18].

IStart
Cap

5'UTR

Stop
Coding sequence

I
3'UTR

Poly·A tail

3'

5'

Figure 2.12: Mature mRNA structure including the UTR regions .

The three prime (3') UTR is found on the 3' side of mRNA and after the stop codon. Several
regulatory sequences may be found on 3' UTR responsible for affecting the stability of proteins and
their cellular localization including miRNAs binding sites, cytoplasmic polyadenylation elements and
zipcode binding domains [20].

2.2

Genomes

A genome is the total amount of genetic information contained in the chromosomes of an organism
and is encoded either in the form of DNA or, for many viruses, as RNA. The genome size for
organisms vary: ranging from a few kilo bases (viruses) to tens of gigabases (human and fi.sh). A
genome includes both the coding as well as the non-coding sequences of the DNA/RNA. Out of
3.2 billion DNA base pairs in the human genome, only about 1.5% code for proteins while the rest
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consist of non-coding genes, regulatory sequences, UTRs, introns, repetitive elements, and intergenic
regions ( http://www.ebi.ac . uk/2can/disease/genes12 .html).

2.3

Genome sequencing

Genome sequencing is the process of determining the sequence and order of DNA nucleotides in a
genome. Almost any biological sample, including saliva, hair, bone marrow, seeds and leaves, can
provide the genetic material necessary for sequencing. Genome sequencing can be used as a valuable
source for finding genes and proteins, their locations, functions, regulations, chromosomal structures
and evolution.

Genome sequencing approaches
Current genome sequencing is not capable of sequencing a complete genome as a single molecule.
An alternative method is to fragment a genome into small pieces and then use a sequencing method
to find the actual genomic sequence for individual pieces and finally combine these sequences to get
the whole genome. In a clone-based sequencing approach, a genome is broken into relatively large
chunks, called clones, about 150,000 base pairs (bp) long. Several copies of a clone are then selected
and fragmented into smaller random pieces (::::: 500 bp) using chemical shearing or sonication [21]
which are sequenced individually. Each of these fragment sequences are then assembled based on
sequencing overlaps to reconstruct the sequence of the whole clone. The whole-genome shotgun approach involves fragmenting the whole genome, sequencing the fragments, and reassembling them
into the full genome sequence. This approach is much faster but complicates the assembly process.
While the clone-based method produces a much more accurate and complete genome, shotgun sequencing is more prevalent due to the greatly reduced cost and the presence of reference genomes that
can greatly facilitate the assembly. Both approaches have been used in whole genome sequencing.
The human genome was sequenced using a combination of these two approaches [22].
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First-generation sequencing
The Maxim-Gilbert (1977) method of DNA sequencing is based on chemical modification of DNA
and subsequent cleavage at specific bases [23]. This method requires the radioactive labeling of the 5'
end of DNA and purification of the DNA to be sequenced. Although fairly accurate and popular at
that time, this method was complex and difficult as it required strand separation before sequencing.
Additionally, it was also considered unsafe because of the extensive use of toxic chemicals.
Sanger and Clouson (1975) used a "Plus and Minus" method to sequence ¢X174 bacteriophage,
the first genome [24]. However, this method was limited by its inability to sequence a double stranded
DNA molecule. Also, this method required both the "plus" and the "minus" strand to determine
the actual sequence.

Sanger modified this technique in 1977 and introduced "chain terminator

sequencing" that is based on the use of dideoxynucleotides triphosphate (ddNTP) in addition to
the normal nucleotides (NTPs) [25]. Dideoxynucleotides are essentially the same as nucleotides
except that they contain a hydrogen group on the 3 carbon instead of a hydroxyl group (OH)
(Fig. 2.13). In Sanger sequencing, many copies of a DNA strand that needs to be sequenced are
replicated using DNA polymerase in the presence of normal nucleotides as well as the appropriate
proportion of dideoxynucleotide bases. The enzyme starts replicating from 5' to 3' end, adding first a
C (correspond to the first G at 5' end of the template strand) or ddC (dideoxynucleotide C). If a ddC
is incorporated then this will prevent further addition of the nucleotides as a phosphodiester bond
cannot form between the dideoxynucleotide and the next incoming nucleotide, and thus the DNA
chain is terminated. If a normal base C is incorporated as the first base then more nucleotides can be
added further. Finally the DNA product is separated using gel electrophoresis. In gel electrophoresis,
the short fragments travel furthest. In Fig. 2.13, C is the first base in the complementary strand.
The next base is again a C, then G and so forth. In this way, the entire complementary nucleotide
sequence can be read. Sanger sequencing greatly simplified the DNA sequencing and was commonly
used for almost two decades.
Sanger and Maxam-Gilbert sequencing were performed manually and was labor-intensive. In
1986, Leroy Hood et al. published an automated method to perform Sanger sequencing that used
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Figure 2.13: Sanger method of DNA sequencing.

fluorescently labeled dideoxynucleosides [26]. Tills sequencing was automated by macrunes where
fl uorescence was detected by laser.

N ext- generation sequencing
Up until mid 2000s macillnes based on Sanger sequencing method were used for sequencing. The
commercialization of genome sequencing started in 2004, when Roche (454) came up with first
massive parallel pyro-sequencing technique with the ability to sequence virtually any genome at
a cost effective price. T his method was based on a "sequencing- by- synthesis" method that relies
on the detection of pyrophosphate released during nucleotide incorporation. Tills method allows
sequencing of a single strand of DNA by synthesizing the complementary strand along it, one base
pair at a time, and detecting willch base was actually added at each step. The amount of light
produced is proportional to the number of nucleotides incorporated. One limitation of this technique
is the inability to distinguish long homopolymer runs in the sequence [27, 28]. lllumina also uses
a "sequencing- by- synthesis" method using a proprietary reversible terminator- based method that
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enables detection of single bases as they are incorporated into growing DNA strands. Since all four
reversible terminator-bound dNTPs are present during each sequencing cycle, natural competition
minimizes incorporation bias. Helicos Biosciences sequences single molecules of DNA or RNA using a
"sequencing-by-synthesis" approach. Applied Biosystems (ABI) uses a "ligation-based sequencing"
protocol. It uses DNA ligase to amplify fragments. Multiple cycles of ligation, detection and cleavage
are performed with the number of cycles determining the eventual read length [29].

N ext-next generation sequencing
The Year 2010 was another landmark in the DNA sequencing. Pacific Biosciences came up with two
proprietary technologies: Single Molecule Real Time Sequencing (SMRT sequencing) and fluorescently labeled phospholinked nucleotides. Using these two technologies and a Zero Mode Waveguide
(ZMW) nanostructure arrays, sequencing can be done in real-time [30]. This technology produces
longer reads but has a relatively high error rate. The Personal Genome Machine(PGM) by Ion
Torrent works on the concept that each natural incorporation of DNA by a polymerase result in the
release of hydrogen ion (H+) which changes the pH of the solution. By measuring the pH it can be
determined whether a nucleotide is incorporated [31, 32].
A comparison of sequencing platforms is shown in Table 2.1.
Table 2.1: Comparison of sequencing platforms
bases per run
(Gigabases)

Run time

NGS chemistry

Roche/454 (GS FLX titanium XLR70)
Applied Biosystems (SOLiD 5500xl)

Read
length
(bases)
450
60

0.45
20 - 25 Gb/day

10 hrs
7 days

Illumina/Solexa (GA IIx)

35-150

11 - 57

2 - 14 days

Helicos (Heliscope)

35 avg.

28

8 days

Pacific Biosciences (PacBio RS)

2200

-

10 hrs

IonTorrent (PGM)

200 bp max

10

2 hrs

Pyrosequencing
Sequencing by ligation
Sequencing by synthesis /
Reversible terminator
Sequencing by synthesis /
tSMS
SMRT
pH difference, semiconductor chip

Platform
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NGS application
NGS technologies have a wide range of applications, and more are being discovered. It has been used
successfully in applications such as variant discovery, targeted resequencing, de novo assembly of
bacterial genomes, sequencing personal genomes and possible usage in personalized medicine, cancer
diagnosis, genes, transcripts and proteins discovery and many other areas.

2.4

Genome alignment and assembly

Next-generation sequencing (NGS) and
high~throughput

next~next

generation sequencing techniques are parallelized

methods that can produce millions of short sequences (reads) in a very short period

of time. The read lengths varies for different platforms ranging between 40-500 bp for NGS and
higher for

next~NGS.

One of the crucial steps of NGS analysis is to map these reads back to their

sequence of origin. These reads can be aligned to either a reference sequence or can be assembled de

novo. Reference-based assembly is easier and often performed; however, in some cases it is unable
to perform mapping accurately. For example, a read may belong to repetitive regions or the read
is not present in the reference genome at all. This section explain two reference based assembly
algorithms which is used in this work for aligning genomic sequences to a genome. BLAST is also
discussed here as it is basis for another BLAT (discussed next).

• BLAST (Basic Local Alignment Search Tool) is a heuristic algorithm for computing optimal
"local alignments" between a query sequence (Q) and a database (D) containing one or more
subject sequences. BLAST has two main components; the first component implements a search
algorithm for finding local alignments and the second component uses an associated theory
for estimating the statistical significance of solutions to help distinguish true similarities from
ones that are due to chance. A BLAST search begins by indexing all words of length k from
the query and then matching each of these words against database sequences. For nucleotide-to-nucleotide searches, each of these matches must be exact whereas for protein-to-protein
searches the matching must have a similarity score 2 T i.e.
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threshold. These scores are

determined using a substitution matrix such as PAM or BLOSUM. When a word match is
found, BLAST attempts to extend the alignment in both directions. BLAST continues this
extension in search of a high-scoring segment pair (HSP). An HSP cannot be extended further
to the left or right if the score drops significantly below the best score achieved on part of
the HSP [33J. The alignments found by BLAST during a search are scored, and assigned a
statistical value, called the "Expect Value". The "Expect Value" is the number of times that
an alignment as good or better than that found by BLAST would be expected to occur by
chance, given the size and composition of both the database and query. BLAST's default
value '10' ensures that no biologically significant alignment is missed; however, high quality
alignments can be obtained by lowering this value.

BLAT: The BLAST-Like Alignment Tool

W. James Kent, in 2002, developed BLAT (BLAST-Like Alignment Tool) tailored to highly

similar sequences, which was faster (500 times faster mRNAjDNA alignment and 50 times
faster for protein sequences) than BLAST. BLAT is similar to BLAST in the way that both
find HSPs. In case of DNA, BLAT works by keeping an index of the entire genome in memory
as the target database. The index uses less than a gigabyte of RAM for the human genome and
consists of all non-overlapping ll-mers except for those heavily involved in repeats. DNA BLAT
is designed to quickly find sequences of ::::: 95% similarity of length 40 bases or more. However,
it may miss more divergent or short sequence alignments [34J. For proteins, BLAT uses 4-mers
and finds protein sequences of ::::: 80% similarity to the query of length::::: 20 amino acids. The
basic difference between BLAST and BLAT is that the former indexes the query sequence
while latter indexes the database sequence. BLAST triggers an extension when one or two
hits occur, while BLAT can trigger extensions on any given number of perfect or near perfect
matches. BLAST returns each area of homology as separate alignments, while BLAT stitches
them together into larger alignments ( http://genome.ucsc.edu/FAQ/FAQblat.html) .
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BLAT uses a seed-and-extend approach for alignments. In the seed (search) stage, it uses an
index to find regions in the genome that are possibly homologous to the query sequence. In
the extend (alignment) stage, it perform an alignment between such regions and then stitches
together the aligned regions (often exons) into larger alignments (typically genes). BLAT provides three different searches in the seed stage [34]: 1. Searching with single perfect matches,
2. Searching with single near perfect matches, and 3. Searching with multiple perfect matches.
The following text describes the first of the three searching option provided by BLAT.

Searching with single perfect K-mer matches:

K: The K-mer size

M: Match ratio between homologous areas,
ments within the same species,

rv

rv

98% for cDNA/genomic align-

89% for protein alignments between human

and mouse.

H: The size of a homologous area. Generally 50 - 200 bp. for human exon
G: Database size, e.g. 3 Gb for human.
Q: Query size.

A: Alphabet size, 20 for amino acids, 4 for nueleotides.

Assuming that each letter is independent of the previous, the probability that a specific K-mer in a homologous region of the database matches perfectly the corresponding K-mer in the
query is:

Let T =

l Jf J denote the number of non-overlapping K -mers in a homologous region of length

H.
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Sensitivity: The probability (of a hit) that at least one non-overlapping K -mer in the homologous region matches perfectly with the corresponding K -mer in the query is:

Specificity: The number of non-overlapping K -mers that are expected to match by chance,
assuming all letters are equally likely, is:

F = (Q - K + 1)

* (GIK) * (lIA)K

These formulas can be used to predict the sensitivity and specificity of single perfect nucleotide

K -mer matches as a seed-search criterion. It was shown that for EST alignments of nucleotide
sequences, a value of K = 14 or less gives at least 99% of the sequences that have 5% or less
sequencing noise.
The extend stage performs a detailed alignment between the query sequence and the homologous regions returned by the previous stage. If a K-mer in the query hits multiple K-mers
in the homologous region, the K-mer is extended by one repeatedly until the map is unique
or the K-mer exceeds a certain size. These hits are then extended as far as possible allowing
no mismatches, and the overlapping hits are merged. These extended hits that follow each
other in the query and target sequences are linked together to get the alignments. In some
cases, stitching of the alignments may be performed when a gene is scattered across multiple
homologous regions.

Bowtie

Bowtie is an ultrafast and memory efficient short-read aligner for aligning DNA sequences to
large genomes. The Bowtie indexer can compress and index the whole human genome into

2.~~

GB of memory. It can align 25 million, 35-bp reads onto the human genome in an hour with a
peak memory footprint of 1.3 GB. Bowtie can align reads ranging from 4 bases to 1,024 bases.
It uses the Burrow-Wheeler (BW) algorithm with Ferragina-Manzini (FM) index to find the

exact match. To allow mismatches and fa.vor high quality reads, it extends the algorithm by
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using a quality- aware backtracking algorithm. It also uses 'double indexing' to limit excessive
backtracking while performing inexact alignments [35, 361. A Burrows- Wheeler transform
(BWT) of a text T is constructed as in Figure 2.14. Initially a $ or any special character
(lexicographically smaller than all the possible characters) is appended to the input sequence.
Next, all cyclic rotations of this text are found in the matrix and are sorted lexicographically.
The last column of each row in the sorted matrix form the actual transform BWT(T) and is of
the same length as the text T. The remarkable property of BWT(T) is reversibility, allowing
the original text to be recreated.

T=
agcaat

_ 1

agcaat$

agcaat$

$agcaat

gcaat$a

aat$agc

caat$ag

agcaat$

l aat$agc

at$agca

at$agca

caat$ag

t$agcaa

gcaat$a

$agcaat

t$agcaa

BWT(T) =
tc$agaa

Figure 2.14: Constructing Burrows- Wheeler transform.

The exact match alignment in Bowtie uses the above sorted matrix and calculates the range
of matrix rows beginning with successively longer suffixes of the query. Bowtie also addresses
inexact alignments that may occur due to sequencing errors or polymorphisms. The algorithm is similar to that of exact match, calculating matrix ranges for successively longer query
suffixes. At any point when the matrix range becomes empty, Bowtie may select an already
matched query position and substitute with a different base. This introduces a mismatch into
the alignment and proceeds with finding the matrix range again. Each substitution is consistent with the alignment policy. Bowtie is a greedy approach and in the case where multiple
substitution positions are found, the algorithm selects the position having the minimum quality value. Bowtie avoids excessive backtracking while balancing the sensitivity of the aligner
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by maintaining two indexes: a forward index and a mirror index. Bowtie limits the maximum
number of backtracks to 125.
Bowtie2 is an upgraded version of Bowtie for aligning comparatively long sequencing reads of
about 50 bp up to 1000 or more. Bowtie2 supports gapped, local and paired-end alignment
modes. For sequences shorter that 50 bp, Bowtie sometimes performs better than Bowtie2.

Other software are available for performing referencfr-based assembly. This include: MAQ (Mapping and Assembly with Quality) [37J is based on the mapping quality concept, ELAND (Efficient
Local Alignment of Nucleotide Data) [38J which searches DNA files for short DNA reads allowing
up to two errors per match and SOAP (Short Oligonucleotide Alignment Program) [39, 40J which
uses a Burrows-Wheeler algorithm to perform alignment and are fast and memory-€fficient.
De novo assembly algorithms assemble the short reads to create full-length sequences. These
types of assemblers are complex, time consuming and memory inefficient as they require many more
comparisons (in the worst case, all possible comparisons) to construct a sequence. Examples of such
assemblers include Velvet [41], ALLPATH-LG [42], Quality Value Guided SRA (QSRA) [43J and
VCAKE [44J. These algorithms are outside the scope of this thesis work and thus not explained.

2.5

The Human Genome Project

The Human Genome Project (HGP) started in October 1990, initially estimated to sequence
the whole human genome in about fifteen years at $200 million per year at a cost rate $1 per base
pair. Sponsored by US Department of Energy (DOE) and National Institute of Health (NIH), the
specific goal of HGP was to identify all the genes in human DNA, determine the sequences of the
three billion chemical base pairs that make up human DNA, store this information in databases,
improve tools for data analysis, transfer related technologies to the private sector, and address
the ethical, legal, and social issues (ELSI) that may arise from the project. The advent of PCR
technology by Kary Mullis [45J and other sequencing methods such as the whole genome shotgun
(WGS) sequencing, cDNA technology and others fueled the competition. Private players including
Celera started using WGS to rapidly sequence the genome. Celera, led by J. C. Venter sequenced

29

the whole genome of Haemophilus influenza in 1995 with this brute-force shotgun strategy [8]. The
competition between public and private was so high that the completion of 'draft' genome was
announced on June 26 t h, 2000. Science and Nature published the genome paper in the same week
of February 2001 [46] [15]. The first draft of the human genome contained roughly three billion base
pairs and was almost 90 percent complete. A startling finding of this first draft was that the number
of human genes appeared to be significantly fewer than previous estimates, which originally ranged
from 50,000 genes to as many as 140,000. The full sequence was completed and published in April
2003.

2.6

Expressed sequence tags (ESTs)

An expressed sequence tag (EST) is a short (200 to 800 base pair in length), unedited single-read
sequence generated by sequencing cDNA. The cDNA itself is prepared from mRNA by an enzyme
called reverse transcriptase [47]. Once the cDNA representing an expressed gene has been isolated,
a few hundred nucleotides can be sequenced from either end to create 5'ESTs or 3'ESTs. ESTs
have been primarily used in the discovery of novel human genes and genomic coding regions since
they represent transcribed sequence. ESTs are a rapid and inexpensive method for understanding
an organism's transcriptome that may be helpful in the prediction of their protein products and
ultimately their function. ESTs of length 150 to 400 base pairs have been shown to contain sufficient
information for similarity searching and mapping which permit the design of precise probes for
DNA microarrays that then can be used to determine the gene expression and other downstream
exploratory analyses.

2.7

Microarrays

A DNA microarray is a collection of microscopic DNA spots attached to a solid surface such as glass
or silicon chip. Each DNA spot contains picomoles of a specific DNA sequence or oligonucleotides,
known as probes. A microarray chip may contain tens of thousands of spots and each of these spots
may contain millions of oligos or DNAs of a particular gene for that spot. A microarray works
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by exploiting the ability of an mRNA molecule to bind, or hybridize to, the DNA template from
which it originated. By using an array containing many DNA samples, scientists can determine,
in a single experiment, the expression levels of hundreds or thousands of genes within a cell by
measuring the amount of mRNA bound to each site on the array. A microarray may be used mostly
in three different ways: 1) In Microarray ExpTession Analysis, expression of a set of genes in one
particular condition can be compared to the expressions of another set of genes in another condition,

2) Microarray Mutation Analysis is used for performing SNP detection and 3) Compamtive Genomic
Hybridization is used mostly by Agilent Technologies to assess genome content in different cells or
closely related organisms.
Three types of microarrays are widely used for analysis of gene expression. The first is based
on short oligonucleotides (oligos), the second is based on long oligos and the last is based on cDNA
technology. Though the short oligo (25-30 base pairs) arrays are the mainstay for expression analysis,
long oligo (50-80 base pairs) arrays are gradually gaining popularity. The cDNA arrays are variable
in length and are also popular among scientists because of flexibility in array synthesis that it gives
to the user.
The major steps while performing microarray experiments are as follows: [48]:

• Sample Prepamtion and Labeling: The RNAs from the tissue of interest are extracted and
are reverse transcribed to produce cDNAs. These cDNAs are then labeled depending on the
platforms being used. Affymetrix uses a single channel biotin-labeled complimentary RNA
for hybridization. Other cDNA arrays use a dual channel approach to label the samples (e.g.
control labeled with green dye and the contrasting sample labeled using red dye) .

• Hybridization: These cDNAs are allowed to hybridize onto the same glass slide. A cDNA
sequence will hybridize to specific spots that contain its complimentary sequence. Hybridization is a complex process and highly dependent on factors such as temperature, humidity,
salt concentration volume of target solution etc, and may be performed either manually or by
robots.
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Figure 2.15: Microarray analysis steps [49]

• Washing: Washing is performed to remove extra hybridization solution to ensure that only
the labeled target on the array is the actual target of interest.

• Image Acquisition: After hybridization, the dyes are excited by a laser at an appropriate
wavelength and scanned by laser that reads the surface. The fluorescence detected are stored
as a digital image usually in tagged image file format (.tiff) into the computer [48].

• Image Processing: In this step, potent ial spots are found and distinguished from spurious
signals. These spots are then quantified by combining the pixel intensity values into unique
quantitative measures that can be used to represent the expression level of the gene deposited
in a particular spot. T his amount is directly proportional to the mRNA present in the solution
that hybridized the chip.

• Data transformation and normalization: The signal intensities are usually transformed and
normalized in several steps in order to improve comparability and signal/noise ratio. The
transformation step may include subtract ion of an estimated background signal and logarithmic

32

transform or subtraction of the reference signal. Microarray experiments involve many steps
and each step can introduce variabilities in the results. These variabilities can be minimized
by performing normalization on the data, including total intensity normalization, quantile
normalization, lowess normalization, linear regression and Chen ratio statistics [50] .

• Analysis of Gene Expression Data: Once the normalized data is available, various techniques
may be used to determine subsets of genes that are significantly changed between conditions.
Determination of the sets of differentially expressed genes is a statistical problem that involves
calculation of a p-value for significance. Example of different methodologies that may be
used include Significant Analysis of Microarray(SAM) [51], Random Forest [52], entropy based

gene selection method [53] and False Discovery Rate(FDR) [54]. A number of software tools
are available to find differentially expressed genes in microarray including SAM, Limma [55],
Multtest [56], twilight [57], Nudge [58], penalizedSVM [59] and RandomForest.
• Once an important gene set is derived from the steps above, a scientist may apply different algorithms to accomplish their tasks, such as classification, clustering and phylogenetic
analysis [60] [48].
Efforts have been taken to standardize microarray data. The Microarray Gene Expression Data
(MGED) society has proposed MIA ME (Minimum Information About a Microarray Experiment)
standard that requires the submitter of the data to furnish some required information such as raw
data for each hybridization, normalized data and sample annotation data processing protocol etc.
This will reduce ambiguity in the data and lead to better interpretation, verification and reusability
of the microarray data. Public repositories such as ArrayExpress at EBI, GEO at NCBI and CIBEX
at DDBJ are designed to accept MIAME compliant data. In addition, most journals (complete list
can be found on http://WWTJ . mged. org/Workgroups/MIAME/ journals. html) now require MIAME
compliant data for publishing a microarray based paper [61].
While microarray techniques have some inherent limitations, they are useful in helping scientists
determine differentially expressed genes, pathway analysis of genes, drug development and drug
response, therapy development, tumor classification and clustering, tracking disease progression,
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alternative splice detection, phylogenetic analysis, mapping deleted or duplicated regions in genome
and mapping genes to phenotype [62] [63].

2.8

Genome annotation

Genome sequencing projects produce huge amount of sequencing data. Genome annotation is the
process of adding the layers of analysis and interpretation to these sequences necessary to extract
their biological significance and place these into the context of our understanding of biological
processes [64]. Genome annotations can be broadly categorized into three levels:

• Nucleotide or structural annotation has the goal of determining the location of sequences and
where do they found on genome including the start and end locations, ORF locations, locations
of non~coding RNAs and regulatory regions, exon landmarks, repetitive regions and mapping
variations.

• Functional annotations are more concerned with what these sequences do, what are the corresponding proteins and their putative biological and biochemical functions.

• Process annotations relate these sequences to various processes such as cell cycle, cell death,
embryogenesis, metabolism etc. and how do they behave in a system (regulations, interactions).

Nucleotide annotation
The first step in genome annotation is to identify the location of genetic elements such as genes,
genetic markers, tRNAs, rRNAs, ncRNAs, repeat regions and ORFs., and the next step is to attach
biological information to these elements. There are a number of algorithms that automatically
annotate these entities.
Gene prediction software identifies the regions of genomic DNA that encode genes. This includes
protein-coding genes as well as RNA genes, but may also include prediction of other functional
elements such as regulatory regions. In ab initio gene finding, the DNA sequence is systematically
searched for certain signals or sequences that indicate the presence of gene. Examples include GENSCAN [65] and geneid [66] algorithms. Advanced gene finders such as GLIMMER (Gene Locator
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and Interpolated Markov ModelER) [67] and GeneMark [68] use complex probabilistic models, such
as hidden Markov models, in order to combine information from a variety of different signal and content measurements. Other algorithms such as mSplicer [69], CONTRAST [70] and mGene [71] use
machine learning techniques like support vector machines for successful gene prediction. Database
projects such as RefSeq, Entrez Gene, Ensembl and ENCODE are involved in annotation of genes
and will be described shortly. Similar to gene prediction algorithms, there are algorithms that search
for non-coding RNAs (such as tRNA, rRNA and snRNA) and transcriptional regulatory regions.
tRNAscan-SE [72] detects tRNA, RNAmmer [73] uses HMMER to annotate rRNA, RNAmicro [74]
and miRNAminer [75] recognize microRNA. Annotations for transcription binding sites are available in curated databases such as TRANSFAC [76] and PROSITE [77]. RepeatMasker screens DNA
sequences in FASTA format against a library of repetitive elements and returns a masked query
sequence along with the annotated masked regions. There are a number of algorithms available to
perform SNP detection and segmental duplication detection. NCBI's dbSNP is a comprehensive
database of SNP annotation.

Functional annotation
Functional annotations seeks to compile a definitive catalog of the functions of specific genomic
regions of the organisms such as protein naming and putative functions. Putative functions can be
computationally assigned using sequence similarity with algorithms such as BLASTP or PSI-BLAST
against the curated database of proteins. UniProtKBjSwiss-Prot [78] is based on this methodology.
The Pfam (Protein family) [79] database is a large collection of protein families and use probabilistic
hidden Markov models (HMMs) for annotating proteins based on functional motifs. NCB! maintains
a protein database which is a collection of sequenees from several sources, including translations from
annotated coding regions in GenBank, RefSeq and third party annotation, as well as records from
SwissProt, PIR [80], PRF, and PDB (Protein Data Bank) [81].

35

Process annotations
Process annotations annotates sequences to its biological processes. For instance, the Gene Ontology
(GO) project is a collaborative effort of associating process level information to the genetic products.
The specific aims of the project is: 1) the development and maintenance of the ontologies themselves; 2) the annotation of gene products; and 3) development of tools that facilitate the creation,
maintenance and use of ontologies. The GO ontology covers three domains: molecular function,
biological process and cellular component. Molecular function describes activities, such as cell cycle,
cell death and embryogenesis, that occur at the molecular level. A biological process is used for
broader biological goals, such as meiosis. A cellular component is just that, a component of a cell,
but with the provision that it is part of some larger object [82].

2.9

Annotation databases

A large number of annotation databases are available that annotate genomes or sequences produced
by various

high~throughput

methods. The Nucleic Acid Research (NAR) 2012 database issue [2]

features 1380 databases covering various aspects of molecular biology including sequences, annotations, gene expression, structures, pathways and diseases. This section gives a brief introduction of
some of the popular annotations databases available.

Ensembl
The Ensembl project, developed jointly by the EBI and the Wellcome Trust Sanger Institute, has
been used for the annotation, analysis and display of vertebrate genomes [83]. Since its inception in
2000, Ensembl added support for many more organisms in its database. Ensemble uses genebuild
pipeline to automatically annotate the protein coding genes,
EST~based

pseudo~genes,

non-coding RNAs and

genes. Ensembl provide genome specific sequence data for all the ensembl transcripts and

genes in different format through its ftp website ftp: / /ftp. ensemb!. org/pub/ current_f asta/.
Unspliced gene sequences, unspliced transcript sequences, exon sequences, cDNA sequences, flanking
region sequences and many more can also be downloaded.
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HUGO Gene Nomenclature Committee (HGNC)
HGNC [84] assigns nomenclature to the human genes following well defined guidelines and store these
into its database. As of May 31 st , 2012, it has approved almost 33,000 symbols; a vast majority
of these are

protein~coding

genes (:::::; 19,000), but also include symbols of pseudogenes, ncRNAs,

phenotypes and genomic features. HGNC also interact with other organism specific nomenclature
committees on regular basis.

The International Nucleotide Sequence Database Collaboration (INSDC)
The INSDC is a collaborative step to maintain a comprehensive database of nucleotide sequences.
It comprises of DNA Data Bank of Japan (DDBJ), the European Molecular Biology Laboratory

(EMBL) and GenBank at NCBI which exchange their data on a daily basis to achieve maximal
synchronization.

GenBank
NCBI's GenBank [85] is an annotated genetic sequence database of publicly available DNA sequences
and their protein translation.

As of April 2011, there are approximately 126,551,501,141 bases

in 135,440,924 sequence records in the traditional GenBank divisions and 191,401,393,188 bases
in 62,715,288 sequence records in the WGS division http://www.ncbLnlm.nih.gov/genbank/.
Sequence data can be submitted through NCBI's GenBank submission system program such as
Banklt and Sequin.

RefSeq
NCBI's RefSeq [86] is a curated, annotated and non--redundant collection of DNA, RNA and protein sequences. Sequences from plasmids, organelles, viruses, archea, bacteria, and eukaryotes are
included in the database. This database can be searched using genomic location, sequence, or text
as query. It is based on records submitted to the INSDC. RefSeq has support for genome annotation,
gene characterization, comparative genomics, reporting sequence variation, and expression studies.
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RefSeqGene
NCBI's RefSeqGene project is a subset of RefSeq and defines genomic sequences to be used as reference standard for well characterized genes. It provides more stable gene--specific genomic sequence
for each gene along with upstream and downstream flanking regions.

UniProt
UniProt [87] provides a comprehensive, high quality and freely accessible resource for protein sequences and their functional annotation. It consists of two sections: Swiss-Prot where the annotations are performed manually and reviewed, and TrEMBL, where the annotations are performed
automatically and are not reviewed.

Entrez
The NCBI's Entrez [88] is a powerful database to search and retrieve sequences, structures and
references for a particular entity. It also provide views of genes, proteins and chromosome maps.
Using a single query, several linked databases can be searched including ESTs, Gene, Genome, GEO
dataset, GEO profiles, probe, PubMed, SNP, structure, taxonomy, UniGene and UniSTS.

Gene
The NCBI's Gene database supplies gene specific information including nomenclature, Reference
Sequences (RefSeqs), maps, pathways, variations, phenotypes, and links to genome-, phenotype-,
and locus-specific resources worldwide.

dbEST
The dbEST database, a division of GenBank stores sequence data and annotation information for
cDNA sequences or ESTs for a number of organisms. dbEST provide a robust sequence resource that
can be exploited for rapid gene discovery, genome annotation and comparative genomics, guiding
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SNPs (Single Nucleotide Polymorphism) discovery, gene structure prediction, investigating alternative splicing and discovering cancer biomarkers [89] [90] [91]. Scientists and researchers across
the world and genome sequencing centers submit tens of thousands of ESTs everyday to NCBI's
GenBank. As of May 1, 2012, the total number public entries of ESTs in NCBI's dbEST repository
was 72,693,656 across more than 2000 organisms http://www.ncbi.nlm.nih.gov/dbEST/dbEST_
summary. html.

The UCSC Genome browser
The UCSC Genome Browser [92] is an online interactive website to access genome annotation data for
a large number of organisms in a variety of ways. It enables researchers to visualize and browse entire
genomes on annotation track for different types of data including gene locations, SNPs, proteins,
expression, comparative analysis, homology etc. A user can also define and view his own custom
track. This is an open source project and all its data is freely available to download via ftp for
non-commercial use. Different utilities and softwares such as BLAT, lift Over and The Genome
Browser can be downloaded freely. The Genome Browser also hosts proteome browser and browsers
for microbial genomes.

GEO
NCBI's Gene Expression Omnibus (GEO) [93, 94] is a public functional genomics data repository
that archives and distributes data from high-throughput experiments such as microarrays and nextgeneration sequencing, serial analysis of gene expression, protein arrays and ChIP-chip data. The
contents in GEO can be describes as platforms, series, samples and datasets. The contents of GEO
can be browsed or text queried. As of May 15, 2012, GEO contains 10,081 platforms, 741,557
samples, 30,107 series and 2,720 datasets.
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Array Express
ArrayExpress from EMBL-EBI is a database functional genomics experiments where data can be
queried or downloaded using MIA ME (Minimum Information About a Microarray Experiment) [61J
standards. It can be queried using accession or keywords.

Affymetrix® N etAffx™
Affymetrix® GeneChip® is one of the microarray platforms that is used widely and most popular
among scientists and researchers. In this technology each gene is typically represented by a set
of 11-20 pairs of probes.

Gene expression is measured by extracting mRNA from the cells or

tissues of interest and hybridizing the mRNA sample to the 25-mer probes on the microarray (Fig.
2.16). Each expressed transcript is represented on an array by a series of probe pairs known as
a probe set. Each pair consists of a perfect match probe, with its 25-base sequence identical to
the gene of interest, and a mismatch probe, whose sequence is the same as the perfect match
except for position thirteen, where the base is set to the complementary of the perfect match. Each
probe set on the Affymetrix® arrays consists of 11 probe pairs, and is given a unique identifier
consisting of a seven digit number, followed by the optional characters
[http://WTiIW.affymetrix.com/support/technical/index . affxJ.

..8,

_a, or -x, and ending in _at

Affymetrix® probe sequences

can be downloaded from the NetAffx'I'M Analysis center at Affymetrix® website.

Affymetrix®

probes give excellent coverage of known genes. For the human genome, as of January 4, 2007,
24,198 of the 24,259 (99.7 percent) sequences present in the RefSeq database were covered by four
or more probes on the Affymetrix® exon array. More than 98 percent of RefSeq and more than 90
percent of the Ensembl protein-coding transcripts were covered by 10 or more probes [96J.
The NetAffx'I'M [97J analysis center details and annotates probesets on Affymetrix®'s GeneChip®
arrays. It annotates each probeset with its composition: the probes that constitute the probeset,
sequence information and the genomic locations, protein sequence-level annotations and associated
ontological terms. Each probeset is structurally annotated using GenBank, LocusLink and Swiss-
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Figure 2.16: Affymetrix GeneChip® design [95]

Prot identifiers as well as func t ional information in terms of GO terms and GenMAPP pathways.
It is a searchable database and can be queried using annotation terms and pro beset IDs.

2.9.1

Agilent Technologies's eArray utilities

Agilent Technologies manufactures a variety of catalog and custom long-oligonucleotide (60-mer)
microarrays that can be used in multiple two-color microarray applications. Optimized methods and
techniques have been developed for two such applications: gene expression profiling and comparative
genomic hybridization. Methods for a third technique, location analysis, are evolving rapidly. A
key component of Agilent's Custom Microarray Design process includes the array layout and basic
QC components of the design process. In array layout which is an aspect of the collaborative design
service that gives you complete flexibility in your design . The processes enables you to rapidly iterate
and print new array layouts. The user has the flexibility to design probes of size ranging from 2560. You can also randomize probe placement on the micro array. Agilent microarrays are used in a
number of different applications such as gene expression profiling, microarrays, comparative genomic
hybridization (CGH) and ChIP on Chip. Agilent provides a web portal in the form of eArray as a
mean to create custom microarrays, enrichment libraries, and mutagenic oligos online. eArray also
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provides facilities including download of the latest annotations for each probe and compare groups
of probes.
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CHAPTER 3
INTERVAL-TREES FOR REPRESENTATION OF
OVERLAPPING GENETIC ENTITIES

3.1

Introduction

The origin of all nucleic acid and protein-based entities is genomic DNA sequences. For species
where a reference genome is available, these DNA sequences can be aligned to the reference genome
and assigned absolute numeric coordinates on the genome. These coordinates consist of information
such as the start and end location(s) on the genome, underlying gaps, and intron--exon boundaries.
Their lengths range from one base (SNP) to kilobases (gene locus), or even megabases (chromosomal
bands). Different databases annotate these entities differently and their annotations tend to show
a large degree of overlap. Fig. 3.1 shows the extent of overlap between the intervals of different
annotations in the region of human BRCA2 (Breast Cancer 2, early onset) gene on chromosome 13.

3.2

Interval representation of genetic entities

Having been assigned numerical coordinates, possibly with gaps (intronic regions), a GE can be
represented as an interval on a genomic scale. As shown in Fig. 3.1, a genetic entity may be a
continuous region (microarray probe, SNP etc.) on the genome or may contain gaps in between
(genes and transcripts). Availability of different types of GEs in different databases, each with
different size (different granularity), complicates its representation as a large number of these entities
overlap each other by sharing same region on the genome.
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Figure 3.1: Different types of GEs in the region of the human BRCA2 gene. Generated on the UCSC
genome browser [98].
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An interval is a convenient representation of events spanning a continuous period of time or
space. Time examples include transactions in a bank, or time spent on a web page whereas space
intervals include map features, photographs, words in a document, or genetic entities (GE). Interval
structures can also be found in application areas such as life sciences, computer graphics, databases,
robotics, computational geomet ry and geographic information systems. All of these problems have
a similar structure, where one entity shares space or time with many other entities.
An interval is an ordered pair [tt, t2] of real numbers with tl, the low- and t2, the high-end
point. If i is an object with an associated interval, then i can be represented as [tt , t2], with tl

~ t2'

An interval may be closed, open or half open. A closed interval can be represented as:

Open intervals are represented as:

Fig. 3.2 shows different examples of one- and two-dimensional interval structures. Fig. 3.2(a)
shows overlapping intervals in one-dimension. An interval i is shown with low end point as tl and
high end point as t2' Fig. 3.2(b) and Fig. 3.2 (c) show the overlapping intervals in 2-dimensions.
I

I
I

I

I

I
I
a

b

c

Figure 3.2: Overlapping intervals in one (a) and two (b,c) dimensions.

James F . Allen, in his paper "Maintaining knowledge about temporal intervals" [99], elaborated
thirteen basic relations among temporal (time) intervals. These intervals are distinct (no pair of
definite intervals can be related by more than one of these relations) and exhaustive (any pair of time
intervals can be represented by one of these relations) and are shown in Figure 3.3. Each relation
relates two temporal intervals X and Y, with the time moving from left to right. These relations
are sorted by the degree to which X begins before Y and then within that by the degree to which
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X ends before Y . All the thirteen basic relations are constituted by six relations and their inverses
and equality relation. T hese are shown in Table 3.1. X

< Y (X

precedes Y) means the interval X

completed before Y started. T he inverse relation fo r this is > (preceded by). Whenever X < Y is
true, its inverse Y > X (Y preceded by X) is always true.
precedes

meets

overlilps finished contilins

stilrts

equills

by

-

X

.J... -

X

X

-L - ..L

-IS- --L. ..A
.J... ...::L ..:L-

I started

±I

during

finishes

overlilpped by

~

-IS-

by

....JL

...::L.

X

..I....

- - y - ....:L..

met by preceded
by

...::L.-

X

..:L.

Figure 3.3: T he t hirteen interval relations defined by J ames F. Allen .

Table 3.1: Basic temporal relations and inverses.
Relation
precedes
meets
overlaps
finished by
contains
starts
equal

Symbol

Inverse relat ion
preceded by
met by
overlapped by
finishes
during
started by
equal

<
m

o
fi
di
s

Symbol

>
mi
oi

f
d
si

In a system with a large number of intervals, there is always a chance they overlap.

Two

intervals must always satisfy the interval trichotomy that exactly one of the following three properties
holds [100] :

1. i and

if overlap (i .e. i n i f

1= ¢ == tl :::;

t~

and tl :::; t2)

2. i is to the left of i f (i.e., t2 < tl) ,
3. i is to the r ight of i f (i .e.,

t~

< t1)

F igure 3.4 shows the interval t richotomy for two closed intervals i an d i'.
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(e)

i'

i'

Figure 3.4: Interval trichotomy

3.3

I nterval t rees

There are a number of data structures and associated algorithms to deal with intervals [100- 103J.
Finding overlapping intervals is an output sensitive algorithm and depends on the number of inputs

n (query intervals) as well as the the outputs m (intervals that map to an interval). Considering
the fact that GEs are large in number , overlap with many other GEs, and are highly dynamic, an
efficient data structure is needed for storage, information retrival, and update.
A red-black tree is a binary search tree having an extra attribute: the color, the value of which
is either red or black. Other than the requirements imposed on binary search trees, a red- black tree
follows the following properties:
• Every node is either red or black.
• If a node is red, then both its children are black.

• The root node is black.
• Every simple path from a node to a descendant leaf contains the same number of black nodes.
• Every leaf node (sometimes called sentinels) is black.
Each node of red- black tree contains the attributes color, key, left, right, and p. If a child or the
parent of a node does not exist, the corresponding pointer attribute of the node contains the value
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NIL. The constraint on the color of the nodes make the tree approximately balanced by ensuring
that, no simple path from the root to a leaf is more than twice as long as any other. The height of
a red-black tree is at most 2 * log2(n

+ I),

where n is the total number of nodes. Since operations

such as inserting, deleting, update and finding values require worst-case time proportional to the
height of the tree, this theoretical upper bound on the height allows red-black trees to be efficient
in the worst-case, unlike ordinary binary search trees.
An interval-tree is an augmented red-black tree that maintains a dynamic set of elements,
where each node i contains an interval storing the two endpoints tdil, t2[i] and max[il, which is the
maximum value of all right endpoints in the subtree rooted at i.
max[i]

= max(t2[i], max[left[i]l, max [right [i]]).

Here, left[i] and right[i] represents the left and right child of node i respectively. Nodes may store
additional information. These nodes are ordered according to the low endpoint of the intervals
and the inorder traversal of the tree always gives a sorted list. An example interval tree is shown
in Fig. 3.5 which is constructed from the intervals shown at the bottom of the figure. Each node
contains end-points of an interval and max (as described in text). The entry in the root node
represents the interval with low-end point as 17, high-end point as 22 and max value as 29.
An interval tree allows dynamic insertion, deletion and search operations to be performed efficiently. Nodes are inserted and deleted in such a way that the properties mentioned above are
always followed. The running time for all three operations is 0(log2n) , and the updating of max
can be done in 0(1) time. When there are multiple intervals (m) that overlap a query interval, the
run time is O(m + log2n). The preprocessing time to construct the tree is 0(nlo92n), with a space
complexity of O(n) [100].
The following operations can be performed on an interval tree:
(a) INTERVAL-INSERT(T, x): add an interval x into the interval-tree T. The running time for
this operation is 0(lOg2 n).
(b) INTERVAL-DELETE(T, x): delete an interval x from the interval-tree T. The running time
for this operation is 0(log2 n).
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Figure 3.5: Example interval tree.

(c) INTERVAL-SEARCH (T, i): return a pointer to a node x in T such that int[x} overlaps interval
i. INTERVAL- SEARCH (T, i) procedure is shown in Algorithm 1. If there is no interval that
overlaps i in the tree, then the procedure returns nil. The running time for this operation is
O(log2 n). if there are multiple intervals that overlap i, then the running time will be O(k +
log2 n), assuming that there are k overlapping intervals. In case of genomic annotations , finding
multiple overlaps is frequent because a particular region on a genome may be annotated at
different granularity level, and by different authoritative organizations.

The preprocessing time to construct the tree is O(n log2 n) , with a space complexity of O(n). The

interval- tree is a special data structure to deal with the type of problem we are concerned about,
since the number of genomic annotations are huge and require frequent insertions and deletions.
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Algorithm 1 Algorithm for searching interval i in tree T [lOOJ.
procedure INTERVAL-SEARCH(T, i)
x f--- T. root;
3:
while x =1= T.nil and i does not overlap x.int do
4:
if x.left =1= T.nil and x.left.max ~ i.low then
5:
x = x.left
6:
else
7:
x = x.right
8:
end if
9:
end while
10:
return x
11: end procedure
1:

2:

3.4

Using interval trees for finding overlapping GEs

Finding all genetic entities (GEs) in a given region of a particular genome is a common task in highthroughput molecular biology experiments. Considering the large number of available annotations
and the fact that the structural annotations are dynamic (frequent insertions and deletions), an
interval tree is implemented to store these annotations and perform various operations efficiently. A
common operation is to find overlapping intervals. To accomplish this, sequence level information for
different entities were downloaded from respective authoritative websites. Those considered include
Affymetrix® and Agilent microarray probes, Entrez genes [88], EST sequences [104], and Ensembl
transcripts [83J. Reference genomes were obtained from the UCSC Genome Browser website (rat
version 3.4, mouse version mm9 and human version hg19). These annotations were then mapped
onto their respective organism's reference genomes using either the BLAT [34J (GE sequence length

> 100 bases) or Bowtie [35, 36J (::; 100 bases) sequence alignment algorithms. For Bowtie alignments,
the maximum number of mismatches allowed was two. Each alignment annotation includes LStart
(the start coordinate on the genome), LEnd (end coordinate on the genome), size (of the mapped
region), and chromosome number. Organism and annotation specific interval trees are maintained.

IRanges [105J is used to incorporate the interval trees. The total number of GEs mapped from rat,
mouse and human genomes are 34.1 million for this test set. These interval trees can be then queried
for overlapping intervals (annotations). The design flow is shown in Fig. 3.6.
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annotations using BLAT and Bowtie
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specif ic interval trees
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Find th e overl appin g genes
and produce t he output.

Figure 3.6: Steps to find overlapping annotations

3.5

R esults

To demonstrate the efficiency of the interval tree implementation, random samples of 10,000 (10k),
50k, lOOk, 500k and 1 million human EST accessions were mapped against themselves to find all
overlapping ESTs. The number of nodes in the tree is increased exponentially adding one level in
the tree at each increment. When the tree is small, the mapping time is less than a second. The
number of overlapping identifiers and elapsed time were calculated five times and averaged. Fig. 3.7
shows the average overlap time plotted against the number of nodes in the interval tree. It took 27.3
seconds to map 10,000 nodes against an interval tree containing 8.27 million nodes, whereas 500,000
ESTs were mapped in 3.8 hours (not shown). The number of overlapping ESTs for 1 million ESTs
was not considered due to memory constraints. The plot shows the run time to be linear as the
number of nodes in the tree increases exponentially. One million randomly sampled EST identifiers
in rat were also mapped to a total of 271 .3 million overlapped ESTs in 276.5 seconds.
Fig. 3.8 shows the average number of overlapping EST identifiers as the number of nodes in the
interval tree is increased exponentially. EST intervals with total number of inputs 10k, 50k, lOOk,
500k and 1 million are given as input to find average number of overlaps. Mapping 1 million ESTs
against an interval tree of size 4.19 million resulted in 787.9 million overlapping EST intervals.
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Figure 3.7: Average elapsed time for mapping ESTs.
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827754e

An interval tree method was implemented and used to query these interval information. For
comparison with relational databases, an equivalent MySQL database was also implemented to perform ID conversion based on coordinate information, and the run time for both of these methods
were compared. Fig. 3.9 shows the run- time comparison of the interval tree and MySQL implementation when randomJy sampled EST IDs from rat are converted to Entrez gene IDs. The number of
EST IDs was increased exponentially for each test point and the corresponding time in seconds was
measured. The run time using the interval tree takes negligible time to map hundreds of thousands
of overlapping genes as compared to the relational database method. The execution time increases
rapidly in the case of MySQL as searching intervals is a linear process. Conversion of one million
EST identifiers into Entrez using the interval tree method took just 11.28 seconds.
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Figure 3.9: Run time comparison for converting EST IDs into Entrez Gene IDs.

Finally, Affymetrix@ HG-U133 Plus 2.0 probes were mapped onto the human genome and the
corresponding intervals determined . These intervals were then queried against the Agilent CGH
105a, GenBank ESTs, and Ensembl transcripts intervals. The number of overlapping intervals and
the elapsed time are shown Table 3.2. Here n represents the number of intervals being queried . The
number of nodes in the interval tree for Agilent CGH 105a, EST and Ensembl transcript is 206712 ,
8277548, and 151222 respectively. Querying 1.02 million intervals from the Affymetrix® probe on
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EST took 42.94 seconds. All of the overlapped Ensembl transcripts and Agilent probes were found
in 3.9 seconds.
Table 3.2: Number of overlapping intervals and overlapping time (sec.)

Size(n)
2
4
8
16
32
64
128
256
512
1024
2048
4096
8192
16384
32768
65536
131072
262144
524288
1026588

3.6

CGH105a
Overlap time
0
4.63
26
3.74
0
3.55
4164
5.51
3146
3.75
3.68
5288
5916
4.68
6234
4.61
7790
4.67
8086
3.72
9018
4.59
11164
4.65
14288
5.47
18690
7.46
25670
6.69
35078
4.91
46740
4.85
54514
4.01
56292
4.03
56302
3.89

EST
Overlap
2258
3117
4186
1862002
1681155
2546796
:3032338
:3769694
4884356
5695468
7100439
10268391
1:3732435
21452652
29380179
41891464
54268926
61601695
6:3060840
63306821

time
26.84
27.97
25.28
30.93
29.28
26.24
29.4
31.63
31.85
33.14
31.43
31.44
30.84
39.53
44.81
54.02
59.75
50.14
51.52
42.94

Ensembl
Overlap time
3.77
318
136
3.48
3.46
265
254878
3.92
4.52
195395
325845
4.66
372675
4.02
395812
5.1
485259
4.05
500769
4.92
4.95
568468
672567
6.05
5.09
801939
1016474
5.19
1344805
4.47
1794852
4.65
2314813
4.85
2673404
5
5.06
2753457
2754880
3.91

Conclusion

An interval tree was implemented as an augmented red-black, tree for storing and querying the
genomic structural coordinates of GEs. The results demonstrate that an interval tree is a better alternative for maintaining data that represents intervals by providing queries that grow in logarithmic
time with respect to the number of annotations present as opposed to the linear growth of relational
approaches. Interval trees serve as a dynamic data structure that can handle insertion, deletion and
search operations efficiently. Representing genetic intervals is one of numerous applications where
interval trees have an edge over contemporary methods in terms of efficiency. These techniques are
readily applicable to others applications such as database transactions, weblogs, and others where
the number of intervals run into tens of millions. Insertion and deletion in an interval tree can be
performed efficiently in log2n time whereas finding overlaps can be performed in O( m
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+ log2n)

time

with a space complexity of O(n). The interval tree method is limited by the fact that it needs to
be in memory all the time to perform interval queries. This may not be as big of a concern as the
memory size in modern computer systems is typically large enough to hold these annotations. However, if data can not fit into main memory, a method such as that proposed by Arge et al. [102J [lmJ
can be used that maintains the interval tree in secondary memory efficiently. The power of interval
trees for querying annotations in genetic entities will prove useful in the context of the information
explosion from high throughput molecular biology technologies such as next generation sequencing,
proteomics and metabolomics.
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CHAPTER 4
ABSIDCONVERT: AN APPROACH TO CONVERT GENETIC
IDENTIFIERS AT DIFFERENT GRANULARITIES

4.1

Introduction

The Nucleic Acid Research (NAR) 2012 database issue [2] features 1380 databases covering various
aspects of molecular biology including sequences, gene expression, structures, pathways and diseases.
Most of these databases are independent of each other and have been created as a result of the respective developers' domain of interest and resource limitations. Due to a lack of standard naming
conventions, most of these databases prefer to assign their own custom generated identifiers (IDs) to
the biological entities. Major public databases such as GenBank [85] and RefSeq [86] use accession
numbers, Gene Ontology (GO) [82] uses a naming convention from organism specific databases,
the HUGO (Human Genome Organization) Gene Nomenclature Committee (HGNC) [84] uses the
gene symbol and a custom generated ID, Entrez [88] uses numeric integers, sequencing projects
use systematic names and biologists sometimes use additional aliases. As an example, the breast
cancer early onset gene has the official gene symbol of BRCA2 provided by HGNC and an associated ID 1101, Ensembl [83] gene ID

ENSG000001~19618,

OMIM (Online Mendelian Inheritance

in Man) [106] ID 600185, HPR (Human Protein Reference) database [107, 108] ID 02554, RefSeq
ID NM_000059, GenBank Accession U43746, Entrez Gene ID 675, VEGA (the Vertebrate Genome
Annotation database) [109] gene ID OTTHUMG0000001741l, UCSC [92, 98] gene ID ucOOluub.l,
UniProt [87] ID P51587, and gene aliases FAD, FAD1, BRCC2, FANCD1, FACD, FANCD.
Fortunately, there is a wealth of information available to the research community in a wide
variety of databases.

However, it is often difficult to extract or integrate information about a
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particular biological entity from multiple resources. For instance, a researcher may be interested
in extracting functional information spread across different databases for a biological entity such as
a gene or a protein; comparing two independent pathways which use different types of identifiers;
or comparing results across species, platforms or labs.

The lack of a common identifier across

these heterogeneous and sometimes redundant biological databases makes the functional analysis of
biological data tedious, time consuming, and error prone.
One solution to handle heterogeneous databases is to use a global identifier for annotations such as
the one described by MIRIAM (Minimum Information Requested In the Annotation of biochemical
Model) [110J. MIRIAM requires a global identifier to contain both the data source as well as an
internal identifier. For example, urn:miriam:hgnc:brca2 is composed of urn:miriam that defines
the notation to be a URN (Uniform Resource Name) using the MIRIAM scheme with data type

hgnc and identifier brca2. This method appears promising and has the potential to solve some of
the previously mentioned problems, but very few databases follow this standard. Another solution
is to manually search for these genes one by one in publicly available databases such as Entrez,
KEGG [111, 112], or GEO [93, 94J and infer their functionality. This method is fruitful when the
number of genes is small, but is impractical for high throughput experiments, where the number of
gene fragments can be on the order of tens of thousands or more. A third solution is to use an ID
converter tool that uses a database to store all possible annotations where a list of IDs may be input
as a query which is then converted into the corresponding target IDs in a precise and efficient way.
One difficulty in the development and maintenance of such conversion tools is the varying granularity of the identifiers. More specifically, the data generated by biological experiments may be at
the locus, transcript, sequence or probe level, with varying coverage of a region of interest (Fig. 4.1).
This granularity ranges from very fine, at the level of DNA microarrays (tens of bases in length, containing probe level information relevant to only a short region of the corresponding mRN A molecule)
through coarser granularity with sequence reads (few hundreds), transcripts (thousands), loci, and
chromosomes. It is also possible that annotations at the same level may have different granularities. For example, among DNA microarray probes, Affymetrix@ probes are usually short (25 bases)
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whereas Agilent probes are longer (60 bases) and cDNA probes are generally;::: 500 nucleotides in
length. The relationships between entities at the same or different granularities may be either 1-1,
I-n, n-l or n-m: for example, an Affymetrix@ probe may span more than one EST; more than
one such probe may be contained inside an EST; a cDNA probe may contain zero, one or more
Affymetrix@ and Agilent probes.
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Figure 4.1: Granularity of annotations

Another difficulty in the development of such tools is the dynamic nature of annotations. Of
late, rapid advances in sequencing and their declining costs have enabled researchers to perform
novel sequencing as well as resequencing projects. These result in an increased depth of coverage of
a genomic sequence, with gaps being filled and repeats more accurately mapped. Sometimes, the
sequence underlying a genetic entity may change, and on a less frequent basis the whole genomic
sequence needs to be updated (as of April 15 th , 2012, the currently available genome versions for
human, mouse and rat are 19 (GRCh37), 10 (GRCm38) and 4 (RGSC v3.4) respectively). These
changes may modify the structural and functional annotations of a genetic entity (GenBank, RefSeq
and Ensembl are updated everyday). Frequent updates in annotations also create problems in the
manufacturing of DNA rnicroarrays. Microarray chips are designed and their probes are annotated
using the current build of a specific genome.

Regardless of the care taken in this design, the
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system will include flaws due to the combination of the delay inherent in the process of microarray
design-manufacture-deployment (compounded by the latency to use) and the dynamic nature of
annotations. Attempts to address these problems have been the focus of a number of previous studies.
Gautlier et al. [113] found redundancies in the annotations of Affymetrix® probes at a sequence
level that map to multiple RefSeq genes. Such ambiguities may result in inaccurate interpretations.
AffyProbeMiner [114] uses RefSeq and GenBank's validated complete coding sequences to regroup
the probes on an Affymetrix® chip into consistent probe sets. In their study, regrouping of the
probes affected almost 65% of the probes on the HG-U133A chip. Harbig et al. [115] reidentified the
Affymetrix® U133 plus 2.0 GeneChip® array probes in an attempt to increase the reproducibility
of microarray experiments. They used BLAST [33] to remap the probes against the genome and
redefined approximately 37% of the probes. These studies suggest that redefinition or reorganization
of probesets will improve the analytical accuracy of the microarray data, a process that would be
greatly facilitated by a means for high-throughput query and mapping/comparison of given sequences
(such as microarray probes) to other genomic annotations stored across a wide variety of databases.

4.2

Currently available ID conversion tools

The problem of ID conversion persists even though a number of tools exist to address this problem.
Some of these are generic and perform ID conversion for probes, genes, proteins, and additional
annotations while others are more specific to DNA microarray probes. Organism support varies
with many of the tools catering to either a single organism or a small set of comparable species. In
addition, cross--species comparison is variable, with most methodologies providing only intra-species
conversion. Almost every approach uses some sort of relational database with the unique identifier
being Ensembl IDs, RefSeq IDs, or custom generated IDs. A brief description of some popular tools
follows.

DAVID (Database for Annotation, Visualization and Integrated Discovery) [116-118] is a web
based structural and functional annotation tool to extract biological meaning from a gene list. It
uniquely generates custom IDs for querying a set of relations and is dependent on annotations from
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other databases. A component of DAVID, DICT [119] (DAVID gene ID Conversion Tool), facilitates
ID conversion.

EASE [120], developed by the DAVID Bioinformatics team, is a customizable,

standalone, Windows® desktop software application, having similar analytic capabilities as that
of DAVID. Babelomics [121, 122] is an integrated web based tool for structural and functional
annotation with an ID converter being one of its components. This component uses a universal index
linked to Ensembl to create a database of 11 species. g:Convert [123], a component of g:Projiler,
allows arbitrary conversion of genes, proteins and probes into one another. Every alias in g:Projiler
is mapped through a three-level index of gene, transcript and protein Ensembl IDs. For each index
level, all corresponding IDs are stored in the database. The Hyperlink Management System and ID

Converter System [124] automatically updates and maintains hyperlink information among major
public biological and chemical databases. It downloads data everyday from authoritative databases
and produces a large correspondence table which is used to show the most up-to-date URL for
genes of interest. Users can use CGI programs to create hyperlinks to this data. Synergizer [125]
assigns a unique internally generated identifier, "peg", to all external IDs that refer to the same
biological entity. It mostly uses the NCBI "gene2accession" file to maintain a database of synonym
relationships and produce a simple web interface.

MADGene [126] uses correspondence tables

and allows conversions in an efficient way. The Clone/Gene ID Converter [127], MatchMiner [128],
the Gene name converter in GeneMerge [129], RESOURCERER [130] and GeneLynx [131] are
additional ID conversion tools.
Some of the ID conversion tools are more specific, such as those that work only at the probe level.

GATExplorer [132] is a web based tool for analysis and visualization of Affymetrix® probes at the
genomic and transcriptomic level. It performs de-novo mapping of all the probes of Affymetrix®'s
expression and exon arrays against the transcriptome of the corresponding organism using BLAST
and records the coordinates on the genome. Unmapped probes are mapped to an ncRNA database
downloaded from RNAdb. Only the perfect match alignment is selected while mapping these probes.
The location of a gene or probe on the genome can be visualized along with all the transcripts present
in that region. NetAffx™ [97]' provided by Affymetrix®, performs ID conversion of Affymetrix®
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probes for different organisms and has a feature to perform structural and functional annotation.
PLANdbAffy [133] is a Probe-Level ANnotation database for Affymetrix® microarrays (HG-U133A,
HG-U133B, HG-U133 plus 2.0, Human Exon 1.0, Human Gene 1.0) that uses BLAT [34] to map
individual probes onto the human genome. These probes are then annotated using information
extracted from RefSeq. ProbeMatchDB [134] uses a number of public databases to perform crossspecies and cross-platform probe mapping. The database conversions are enabled by UniGene and
HomoloGene identifiers. UniProts [78, 135] ID mapping tool works on the gene and protein level
and converts gene IDs into UniProt IDs and vice versa.
Some software tools have unique methods for mapping between different IDs.

Onto~ Translate

[60,

136] converts one type of IDs into another by calculating the optimal path between IDs, taking into
account the "trustworthiness" of data contained in various databases. The AliasServer [137] uses a
custom generated unique 64-bit reference identifier which is computed from the amino acid sequence
using the CRC (Cyclic Redundancy Check) algorithm where each ID is a unique combination of
species identifier, type of database and the ID itself.
Some databases/tools aid in ID conversion but do not function as a full fledged ID conversion
tool. BioMart [138, 139], earlier known as EnsMart [140], provides a web and API interface to
download data such as GO terms, genes, transcripts and expression arrays from different databases
using filters. BridgeDb [141] provides an interface to connect bioinformatics tools such as Cytoscape,
PathVisio, or WikiPathways with other mapping services such as Ensembl, PICR (Protein Identifier
Cross-Reference services) [142], and any local database or text files. It is intended to be used by
bioinformatics developers and works on the novel idea of mapping custom identifiers to established
identifiers such as Ensembl ID and then relies on Ensembl to provide the rest of the conversion. Side
by side feature comparisons of these tools are provided in Table 4.1. Data sources for select tools
are listed in Table 4.2.
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Table 4.1: Feature comparison of different conversion tools.
Caters to

Name

probes,
genes,
prots.
probes,
genes,
prots.
genes , prots. and
probes
genes, prots. and
bio. molecules
probes, genes and
Prots.

DAVID
Babelomics
g:Convert
HMS and IC
Synergizer
Clone/Gene
Converter

ID

MADGene
GATExplorer
0)

NetAffxTM

tV

intervals seqs
to IDs
to IDs

PLANdbAffy
probeMatchDB

./

Annot
ID
lookup View
./

Iinkou

Query
mode

Input

Output

Annot

./

./

batch

select one

select one

S, F

./

./

batch

select one

select
multiple

S, F

batch

select one

select one

S,F

batch

select one

select one

./

batch

select one

./

batch

select one

./

batch

NA

./

./

single

probes

./

./

batch

./

./

single

genes and prots.
probes,
genes,
trans.
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Table 4.2: ID converter tools, data sources and availability.
Name
DAVID
Babelolllies
g:Convcrt
HMS and IC
Synergi~pr

Clonp/Gellc
ID
Converter
MADGenc
GATExplorcr
NetAffx'M
PLANdbAffy
probeMatchDB
Uniprot
Onto-Translatp
AliasScrvpr
MatchMiIlPr
GencMerg(,
BioMart
BridgcDb
AbsIDconvert

Data Sources
GenBank. Rd'Seq. KEGG, OMIM, Un iGenp
Go, KEGG, Ensclllbi and others
GO, KEGG, Enselllbl, TRANSFAC.
Reactollle
Enselllbl, GO. KEGG and others
Enselllbl, NCB!, RGD, SGD, KEGG.
WorlllBasc and EcoCyc
Enselllbl, NCB!, Pubmed. UCSC,
KEGG, Reactome
GEO, UniGene, Entrc~ and others
Ensembl, Affymetrix®
NCB!, GO. KEGG and others
Affymctrix®, VCSC, NCB!
VniGcnc, HOlIloloGenc
GellBank. Ret'Seq, GO and others
Enscmbl, GO. KEGG and others
Ensembl, EMBL, NCBI, SGD and others
Affymetrix®, UCSC, UniGenc, Entrl'~.
OMIM
GO,KEGG
NCBI, GO, KEGG and others
Ensembl and others
UCSC, NCB!, Enselllbl,
Agilent.
AffYlIlctrix® and others

63

Webpage
http://david.abcc.ncifcrf.gov/
http://babelomics.bioinfo.cipf.es/
http://biit.cs.ut.ee/gprofiler/
http://biodb.jp/
http://llama.mshri.on.ca/synergizer/translate/
http://idconverter.bioinfo.cnio.es/
http://wvw.madtools.org/
http://bioinfow.dep.usal.es/xgate/principal.php
wvw.affymetrix.com/analysis/netaffx/
http://affymetrix2.bioinf.fbb.msu.ru/
http://brainarray.mbni.med.umich.edu/Brainarray/
http://www.uniprot.org/
http://vortex.cs.wayne.edu/
http://cbi.labri.fr/outils/alias/
http://discover.nci.nih.gov/matchminer/index.jsp
http://genemerge.cbcb.umd.edu/
http://www.biomart.org/
http://www.bridgedb.org/
http://bioinformatics.louisville.edu/abid/

4.3

Drawbacks associated with existing approaches

Most of the ID conversion tools mentioned above use a two step conversion method. To convert
an ID A to ID B, the first step is to use a correspondence annotation relation or table to find a
common intermediary ID C (Fig. 4.2). This common ID C is then converted into target ID Busing
another correspondence table. Some tools use Ensembl or RefSeq as an intermediary while others
generate unique custom identifiers. For example, the Clone/Gene ID Converter and GATExplorer
use Ensembl ID, PLANdbAffy uses RefSeq whereas DAVID and Synergizer use a custom generated
DAVID ID and peg respectively. These tools convert smaller fragments (probes, sequences, reads)
into coarser genetic entities (Ensembl, RefSeq, EntrezID) using inferred annotation level information
irrespective of the fact that these small fragments may not be representative of the annotation as
a whole. These methodologies also tend to lose structural and other information available at the
probe or sequence level.

A- -

-

-

-

-

-

-

-

--6

C
Ensembl. RefSeq.

peg.
custom generated 10

Figure 4.2: ID Conversion -- A two step process.

As stated previously, annotations are dynamic and databases such as Ensembl and RefSeq are
updated daily making it difficult to keep the databases of ID conversion tools current. This is
more problematic when the interme<;liate IDs are custom generated as these require more effort to
update. Most of the tools are based on a relational database and the dynamic nature of annotations
may introduce database anomalies because of the frequent insertion, deletion and updating of the
annotations. If a gene is discovered, deleted or updated in any of these databases, or the annotations
corresponding to an entity are added, deleted or updated, then all the databases or correspondence
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tables also need to be updated. In the case of microarray experiments, if a probe corresponds to a
recently deleted entity then that probe annotation needs to be edited as well. Updating any of these
authoritative databases may induce a chain-reaction for any other systems using that information
and any experimental result deduced from the updated probe may become invalid. Those tools that
generate their own unique identifier such as DAVID, Synergizer or Babelomics, although efficient,
face a similar situation and need to be updated frequently. As updating an annotation database is
labor and resource intensive, some of the tools cannot afford to update their knowledge base regularly.

4.4

Absolute (sequence based) method for ID conversion

A feature of biological entities that is currently ignored in ID conversion is the sequence mapping
information. For species where a reference genome is available, all nucleic acid and protein-based
annotations, no matter the granularity, can be aligned to that reference genome sequence and therefore annotated by genomic intervals. Once the absolute genomic coordinates on a reference genome
for all entities have been determined, these can be queried to find all overlapping entities, thus performing ID conversion. This conversion uses the same two step method as adopted by most of the
ID conversion tools, considering the genomic coordinates as the basis of conversion, rather than the

annotation level information used by other tools. Compared to other types of intermediate IDs, the
intervals on a reference genome sequence are relatively static, and remapping of entities to modified
genomic sequences is relatively trivial, making it possible to easily update the system. Using interval
trees, conversion by finding overlapping intervals is fast and efficient [143J.
Fig. 4.3 shows the steps to perform sequence-based or absolute ID conversion. In the figure, all
transcripts corresponding to probe A are being found. The first step (step 1) in this conversion is
to find the genomic coordinates corresponding to probe A and the second step (step 2) is to find
all transcripts that span those coordinates. In this example transcript 2 and transcript 3 are the
converted IDs corresponding to the probe A. Transcript 1 is not represented by probe A as the
underlying genomic sequence is not part of transcript 1. Subsequent sections describe the design
and implementation of a genomic interval based ID conversion tool, AbsIDconvert.

65

Sources
Locus Level

LocusL~k

10
Entrez Gene
HomoloGene
UCSC Gene
HGNC Gene

Transaip level

----.
- - -

• •

•••

R ASeq
SAGE
EST

Allymetn<
Agllent
cONAArray
Oligonucleotide

Genomic Sequence

Figure 4.3: Absolute ill conversion process

4.5

System design and implementation

The design of AbsIDconvert was accomplished using a preprocessing and a query step. In the
preprocessing step, reference genomes were downloaded from the uese Genome Browser (http :
/ /hgdmmload. ese. uese . edu/downloads . html) and the NeBI website. The sequence information
for a variety of identifiers at different granularities such as probes, sequences (ESTs), transcripts and
genes were downloaded from their respective authoritat ive websites or uese. The identifier types
include Affymetrix@ probes, Agilent probes, EST sequences, Ensembl transcripts and Entrez genes.
Each identifier sequence was mapped to the respective genome using either BLAT [34] or Bowtie [35].
BLAT was used to map longer (>100 BP) sequences, while Bowtie was used for relatively short (::;
100 BP) sequences such as Affymetrix@ and Agilent probes. Each identifier was then annotated with
structural information such as start (identifier's start coordinate on genome), end (the end coordinate
on the genome), size (sequence size) and chrom (corresponding chromosome). This information
was collected for each identifier as a genomic interval. Genetic entities with multiple exons such
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as transcripts were treated differently as there are two ways in which these can be structurally
annotated. One method is to use the extreme ends (i.e. start and end codons of the transcript)

as their intervals including both the exons as well as intronic regions, or alternatively exclude the
intronic regions and assume the transcript's genomic intervals are an assembly of genomic intervals
of the participating exons (AbsIDconvert incorporates both). Finally organism and identifier type
specific interval trees were constructed and stored. A list of all identifiers and their type was also
stored in a relational database to facilitate batch look-up for the types of identifiers. Fig. 4.4 shows
the design steps of AbsIDconvert.
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Figure 4.4: Steps involved in the construction of AbsIDconvert.

Once structural annotation for each of the identifiers is available, AbsIDconvert can query this
information. This query step uses the structural annotation information of each identifier and the
organism specific database generated from the previous step. AbsIDconvert assumes two biological
entities (nucleic acid, protein entity) are the same if their genomic sequences are also the same,
overlap or one is contained within the other. As the number of annotations are large and frequent
insertions and deletions are routine, an efficient data structure for storage and computational operations is needed. Considering that the structural annotation is in the form of genomic intervals, a
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modified Red-Black tree, known as an interval tree, is used to store the information for all IDs. An
interval tree maintains a dynamic set of elements, with each element x containing an interval int(x).
This int(x} stores the start and end of the interval apart from other auxiliary information. This data
structure is dynamic in nature and can perform insertions and deletions efficiently in time O(1092n),
where n is the number of elements. Interval trees have been shown to be efficient for working with
a large number of genomic intervals as covered in Chapter 3
There are four possible ways in which AbsIDconvert may be queried:
• Lookup identifiers: Given a mixed list of identifiers, AbsIDconvert can determine the types of
identifiers in the list. This step uses the relational database created in the preprocessing step
and can efficiently categorize the IDs in the list .
• Batch conversion of IDs: Given a list of identifiers, AbsIDconvert uses the interval tree to
find their genomic coordinates. Once the coordinate information is available, all overlapping
identifiers can be found by querying the interval tree. This uses the IRanges [144] and GenomicRanges [105] packages internally to maintain the genomic intervals which are based on
Allen's Interval Algebra [99]. Users can specify various range parameters using the interface.
The overlap type ('type') parameter may take anyone of 'any', 'start', 'end', 'equal' or 'within'
as its value. By default 'any' overlap is accepted. If 'type' value is 'start' or 'end' then the query
intervals are required to have matching 'start' and 'end' respectively with subject intervals in
the database. If 'type' is 'equal' then only those subjects are retrieved which have the exact
same coordinates. For 'within', the query must be contained wholly within the subject intervals. Another parameter is for specifying the maximum gap ('maxgap') between subject and
query intervals to consider them as overlapping. The default value is zero which assumes there
should not be any gap between the subject and query intervals. This parameter is useful for
finding genes in the flanking regions of the specified intervals. The third parameter is the minimum overlap ('minoverlap') size that specifies the minimum number of overlapping base pairs
needed to consider the query and subject an overlap. The default overlap value is one. The
last parameter is the 'select' parameter that specifies which type of overlaps will be reported.
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By default, all overlapping intervals will be reported. Selecting 'first', 'last' and 'arbitrary'
will report first, last and arbitrary overlapping intervals from the result. A simple example
using intervals is shown in Fig. 4.5. In this case, the reference genome is 10 BP long. The
subject database contain four intervals sl, s2, s3 and s4 that represent the interval database.
Query intervals also consist of four intervals ql, q2, q3 qnd q4. Considering default values for
range parameters, ql overlaps with sl, q2 and q3 overlap with all the intervals in the subject,
whereas q4 overlaps with s2, s3 and s4 . If the values of the parameters are type= 'wi thin , ,
maxgap = 0, minoverlap=l, select= 'all' then ql overlaps with sl, q2 with s2 and q4 with s2
and s3. If the values of the parameters are type= 'end ', maxgap = 1, minoverlap = 1, select=
'all' then q2 overlaps with s2, q3 with s3 and q4, and q4 with s2.
Reference Genome
1

2

3

sl

4

5

7

6

8

9

10

Subject Database

s2
s3

s4

Query Intervals

ql
q2

q3
q4

Figure 4.5: Example of interval overlaps .

• Intervals as input to AbsIDconvert: A unique feature of the ID conversion is to find target
identifiers corresponding to a given interval. For example, ne>.."t-generation sequencers generally
map the DNA sequences or reads to a reference genome and output the intervals for each aligned
reads. Finding desired target identifiers corresponding to these intervals is routinely required.
AbsIDconvert efficiently converts these coordinates into target identifiers in a high throughput
manner. For instance, a user of AbsIDconvert is able to take a set of intervals upstream of
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a set of transcription start sites to determine if any features are annotated proximal to the
regions of interest .
• Sequences as input to AbsIDconvert: Sometimes a user may be interested in finding all identifiers that correspond to a particular sequence or a list of sequences. For instance, a user may be
interested in finding all gene names and Entrez IDs corresponding to a set of sequences. In this
case, AbsIDconvert maps these sequences to the corresponding genome (or any other genome
for cross-species comparisons) and determines the genomic intervals they belong to and then
retrieves all the desired target identifiers that overlap these intervals. Due to the computational complexity involved in mapping long sequences using a generic mapping algorithm such
as BLAT or BLAST, the web version of AbsIDconvert supports only short sequence mapping
using Bowtie. Longer sequences can be mapped using BLAT in the virtual machine version of
AbsIDconvert. Sequence output from next-generation sequencing technologies can be catered
efficiently using AbsIDconvert. Alternatively, the coordinate information may be obtained by
submitting the sequences to Galaxy [145-147] or the UCSC genome browser and subsequently
inputting the intervals using AbsIDconvert. Mapping parameters can be specified by the user
through the interface. Parameters include the maximum number of mismatches which can
range from zero (default) to three. The second mapping parameter specifies which type of
alignments are to be reported. The default value is 'all Best' in which all best alignments
will be reported by Bowtie. However, 'all', 'k' or 'k Best' can be selected for Bowtie output.
AbsIDconvert also has another parameter 'Do not report ( .. more)' that takes a positive integer
value which specifies that Bowtie will suppress all alignments for a particular read if the total
number of reportable alignments for that read is more than the specified value. The default
value of -1 specifies that all alignments will be accepted. For instance, if this value is set to
100, then Bowtie will suppress all those alignments for reads that map to 100 or more locations on the genome. This is an effective option to mask repeat sequences or small sequences
from appearing into the output because their probability to map at multiple locations on the
genome is higher.
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AbsIDconvert supports 53 major species for performing ID conversion on a list of identifiers and
a list of intervals. It also has sequence level mapping support for 12 major species including Homo

sapiens, Mus musculus, Rattus norvegicus, Bos taurus, Gallus gallus, Sus scrofa, Xenopus tropicalis,
Anopheles gambiae, Drosophila melanogaster, Caenorhabditis elegans, Saccharomyces cerevisiae, and
Danio rerio. AbsIDconvert converts the input (intervals, IDs and sequences) into target identifiers
with links to authoritative databases. All intermediate interval files are available to download for
later use. It also generates custom annotation files that can be used to view the IDs simultaneously
(chromosome-wise) as a custom track in the U CSC Genome Browser. The performance and potential
uses for AbsIDconvert are discussed in the following sections.

4.6
4.6.1

Results
Intervals vs. relational database

The genomic coordinate information for different identifier types mapped to 53 species were stored as
intervals. An interval tree method was implemented and used to store and query the corresponding
interval information for each identifier type. For comparison with relational databases, an equivalent
MySQL database was implemented to perform ID conversion based on coordinate information, and
the run time for both of these methods were compared.
Run-time comparisons of the interval tree and MySQL implementations were performed using
randomly sampled rat EST IDs which were subsequently converted to Entrez gene IDs. To test
the actual runtime, the number of EST IDs was increased exponentially for each test point and the
corresponding execution time (in seconds) was measured. The run time complexity of the interval
tree maintained a constant rate while the relational methodology grows in linear fashion, allowing
for the conversion of millions of identifiers in only a few seconds (Fig. 4.6).
Further analysis of conversion runtime was performed using 1000 random sampled IDs from
Affymetrix® Rat230_2 microarray probes, Agilent Cgh105a microarray probes, RefSeq IDs, EnsembI transcripts, Entrez genes, HUGO gene symbols and EST IDs which were converted into one
another using the web version of AbsIDconvert (Table 4.3). The extreme left column represents the
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Figure 4.6: Run time comparison between MySQL and interval-trees approach.

source identifiers which are converted to target identifiers shown in first row. The numbers in small
parentheses in the first row show the total number of genomic coordinates for individual ID types
(For instance, Affymetrix® Rat230...2 .0 probes have altogether 231,971 intervals stored). Since AbsID convert suppor ts conversion to multiple target types, the last column represents the time elapsed
when an input type is converted into all other ID types.
Table 4.3: Run time (sec.) to convert 1000 IDs from one type to another using web-based AbsIDconvert.
x.at:tJU~

Affymetrix Rat230.2
Agilent Cghl05a
RefSeq
Ensembl transcript
Entrez gene
Gene symbol
EST sequences

4.6.2

(23 1.971)
5.6
5.1
4.5
2.9
2.7
2.9
18.6

vgnlU:>a
(97.973)
3.2
3.9
3.1
3.8
2.9
2.8
17.6

Kell>eq
( 160.644)
4.1
2.5
3.6
3.1
2.8
2.7
31

r;ru;'Hans
(349.445)
7.6
2.7
3.6
4
3
2.9
30.3

r;ntrez gene
(30.972)
3.2
2.92
2.3
2.47
7.5
8.5
28.3

t;enel>ymool
(30.972)
3.3
3.05
2.2
3.02
7.1
7.5
29.3

r;I>T seq
(3.9 18,403)
33
31.3
31.9
34.6
18.4
16.6
64.1

All
47.6
55.6
34.5
47.1
35.3
38.2
73.7

Run- time comparison

Direct comparison to other ID conversion approaches is not straightforward due to the differences
in annotation information (based on the last available update), supported ID types, and development/deployment platforms.

In order to test the runtime of comparable solutions (DAVID,
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Clone/Gene ID Converter, GATExplorer, MADGene, and AbsIDconvert) , a varying number (100
to 30,000) of Affymetrix® Rat230...2.0 microarray probesets were converted to Entrez IDs (Fig. 4.7).
When the number of probes sets converted was small (100), the conversion time for all tools was
nominal . For a moderate number of probe sets (5 ,000) MAD Gene, DAVID and AbsIDconvert performed similarly (12.6, 6. 1 and 5.1 sec. respectively) , while GATExplorer took around a minute
and Clone/Gene ID Converter took 15 minutes (Fig.4.7(a)) . As the number of probe sets further
increased, all of the tools, with the exception of MADGene and AbsIDconvert , were incapable of
tractably handling such a large number of inputs. Since the Affymetrix® Rat230...2.0 has roughly
31,000 unique probe sets and over 300,000 individual perfect match probes, a run time comparison
for a large number of inputs (> 30, 000) was performed by converting randomly sampled human
transcripts into Entrez IDs (direct conversion of individual probes is not possible within all of the
tools; therefore the closest comparison is made to the same number of human transcripts) . For
100,000 inputs, only MADGene and AbsIDconvert completed successfully, taking 45 sec and 24 sec,
respectively (Fig.4.7(b)). Note that DAVID limits user input to 30,000 identifiers. The run- time
complexity for AbsIDconvert compares favorably to other similar tools, demonstrating its applicahility in the analysis of high throughput data.
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Figure 4.7: Run time comparison for ID conversion.
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4.6.3

Output accuracy

The accuracy of conversions performed using AbsIDconvert was assessed based on the overlap of
the successfully converted IDs with those found using other tools for three types of conversions.
In the first conversion, 1000 unique Entrez IDs were randomly sampled from the "org.Hs.eg.db"
Bioconductor annotation package and converted to their corresponding official gene symbols. Ten ID
conversion tools, from a total of 19 tools listed in Table 4.1, can perform this conversion. Considering
NCBI as the authority for Entrez IDs, the accuracy of different conversion tools were evaluated using
the following assumptions:
1. NCBI contains the most up to date information and its annotations are correct.

2. An Entrez ID may be annotated by more than one gene symbol.
3. Given an Entrez ID x, if a tool converts x to a set of gene symbols, Y (x --+ Y), and NCBI
annotates x to another set of gene symbols, Z (x --+ Z), then accuracy terms can be defined
as:

• True positives (TP) are those conversions in which the converted gene symbol set
contains all the gene symbol(s) annotated by NCBI (i.e. Z

~

Y).

• False positives (FP) are unexpected results. This includes incorrect conversions (Z

%

Y), as well as those conversions in which NCBI does not annotate an Entrez ID with any
gene symbol, but a tool finds some gene symbol corresponding to that Entrez ID (Z = dJ
and Y =J ¢).
• False negatives (FN) are missing conversions in which a tool could not find corresponding gene symbol(s) (Z =J ¢ and Y = ¢).
• True negatives (TN) are the correct absence of conversion in which NCB I as well as a
particular tool does not convert an Entrez to any gene symbol (Z

=J ¢ and Y =J ¢).

4. Accuracy is defined as

TP+TN
%Accuracy (ACC) =, TP + TN + FP + FN x 100
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Table 4.4 shows the contingency table and associated statistics for the conversion of 1000 Entrez
IDs to gene symbols. AbsIDconvert converted a total of 885 Entrez IDs with an accuracy of 87.2%
followed by DAVID (853, 79.1%), MAD Gene (854, 73.1%) and HMS & IC (724, 72.9%). Although
Onto-Translate converted a total of 823 Entrez IDs, it has more FP conversions than HMS & IC and
therefore a lower accuracy. We further investigated the conversions from the top four tools on the
basis of their accuracy and summarized the results in a Venn diagram (Fig. 4.8(a)). AbsIDconvert
converted a total of 83 Entrez IDs which are missed by the other tools. NCBI places all these
Entrez IDs onto the reference genome and annotates them with gene symbols that are in agreement
with AbsIDconvert (Table A.l). Of these 83 Entrez IDs, 48 are categorized as "pseudo", 27 as
"miscRNA", four as "protein-coding", three as "unknown" and one as "other". AbsIDconvert was
unable to convert a total of 115 Entrez IDs, out of which 21 IDs were not converted by any of the
tools examined.
Table 4.4: Entrez ID to gene symbol conversion accuracy.
Tool
AbsIDconvert
DAVID
MADGene
HMS & IC
Onto-Translate
MatchMiner
Clone/Gene ID converter
g:Convert
Synergizer
Babelomics

totalMapped
885
853
854
724
823
539
537
445
445
486

TP
866
790
730
723
722
457
441
433
433
421

FP
19
63
124
1
101
82
96
12
12
65

FN
109
146
145
270
176
458
457
549
549
508

TN
6
1
1
6
1
3
6
6
6
6

TPR
88.82
84.40
83.43
72.81
80.40
49.95
49.11
44.09
44.09
45.32

FPR
76.00
98.44
99.20
14.29
99.02
96.47
94.12
66.67
66.67
91.55

ACC
81.20
19.10
13.10
72.90
72.30
46.00
44.10
43.90
43.90
42.10

FDR
2.15
7.39
14.52
0.14
12.27
15.21
17.88
2.70
2.70
13.37

Fl..score
93.12
88.32
84.44
84.22
83.90
62.86
61.46
60.69
60.69
59.51

Of the 94 Entrez IDs that AbsIDconvert was not able to convert but other tools were (Table A.2),
most were either "not on current assembly", meaning that the reference sequence for that Entrez
ID could not be mapped to the current genome (28 IDs), but could be mapped to previous genome
assemblies; or "not annotated on reference assembly", indicating that the sequence cannot be found
on the reference assembly at all (61 IDs). Five conversions were found where the Entrez IDs reported
had since been deleted and replaced (DAVID and MAD Gene both converted these IDs).
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In a second conversion test, 1000 randomly sampled Entrez IDs were converted to RefSeq IDs
using ten of the 19 tools listed in Table 4.1 (the others are not able to perform this type of conversion
and were not evaluated). There are many different classes of RefSeq IDs, including mRNA (ID starts
with NM_ ), RNA (NR_ ), protein (NP _ ), as well as predicted versions of each one (XM_ , XR_ and
XP _ respectively). How RefSeq IDs are segregated for conversion differs among the tools tested.
For example, a number of tools combine all the different types of RefSeq IDs into one converted ID
type while others treat each one separately. Other tools ignore the predicted RefSeq IDs and only
consider mRNA and RNA. For example, AbsIDconverts RefSeq database combines both mRNA and
RNA, whereas MAD Gene includes predicted products (XM). DAVID and Synergizer have separate
options for RNA and mRNA RefSeq. Therefore, to enable comparison between all the tools, only
those conversions that result in mRNA or RNA RefSeq IDs are considered, and for those tools that
report them separately, the results from both conversions were combined. In addition, any predicted
RefSeq IDs (i.e. those that begin with X) were removed.
Using the same assumptions as reported for the Entrez to Symbol conversion, the accuracy of
conversion for each tool was calculated (Table 4.4). Of the 1000 Entrez IDs used, NCBI annotates
only 599 with one or more RefSeq. In this case, the accuracy for the various tools ranged from a
high of 75.6% (AbsIDconvert) to a low of 38.9% (HMS & ID).
Table 4.5: Entrez ID to RefSeq conversion accuracy.
Tool
AbsIDconvert
MADGene
Onto-Translate
DAVID
Synergizer
g:Convert
MatchMiner
Babelomics
Clone/Gene ID converter
HMS & ID

Total Mapped
586
551
501
549
482
482
474
501
421
461

TP
362
335
291
311
278
278
268
267
219
227

FP
224
216
210
238
204
204
206
234
202
430

FN
20
49
99
72
121
121
126
128
195
181

TN
394
400
400
379
397
397
400
371
384
162

TPR
94.76
87.24
74.62
81.20
69.67
69.67
68.02
67.59
52.90
55.64

FPR
36.25
35.06
34.43
38.57
33.94
33.94
33.99
38.68
34.47
72.64

ACC
75.60
73.50
69.10
69.00
67.50
67.50
66.80
63.80
60.30
38.90

FDR
38.23
39.20
41.92
43.35
42.32
42.32
43.46
46.71
47.98
65.45

FLscore
74.79
71.66
65.32
66.74
63.11
63.11
61.75
59.60
52.46
42.63

The results from the four most accurate tools were investigated further. 497 Entrez IDs were
converted commonly by all tools (Fig. 4.8(b)). AbsIDconvert converted 586, followed by MADGene
(551), DAVID (549) and Onto-Translate (501). Five conversions specific to MADGene were not
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fOtUld by AbsIDconvert (Table A.3). In this case, AbsID onvert correctly mapped the Entrez IDs
to the genome (Table A.4): however, the corresponding RefSeq IDs were not in the data obtained
from VCSC. Other conversions that AbsIDconvert did not report were found to be false positives
reported by other tools. For example, DAVID and Onto-Translate both reported converting "4586
to

"N~L017511"

and 1'441956" to mvLOO1013729"j however, the genomic intervals for those IDs do

not overlap, and both RefSeq IDs are shown in )lCBI as '-permanently suppressed". For the twenty
conver ions specific to DAVID, the reported RefSeq IDs were found to be associated with different
Entrez IDs in NCB! (Table A.5).
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Figure 4.8: Velm diagram showing the conversion results.

The thirty-eight Entrez IDs converted only by AbsIDconvert were investigated further to verify
whether they were "correct". Thirty-three are in agreement with the NCB! data (Table A.6). For
the other five, we examined the genomic intervals of both the Entrez IDs and reported RefSeq IDs
to verify that they do indeed overlap (interval are reported in Table A.7). In all cases the converted
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IDs do have overlapping intervals with two of the Entrez IDs discontinued and replaced since the
initial construction of the AbsIDconvert database, "100505905" (to "23189" on March 2, 2012) and
"100652874" (to "100505641" on Feb 3,2012).
To better assess the accuracy of AbsIDconvert compared to other tools, the Entrez to RefSeq ID
conversion was repeated ten times, randomly choosing 1000 Entrez IDs each time. Out of the 10,000
randomly selected Entrez IDs, 8,974 were unique. AbsIDconvert converted 5700 (63%), followed by
MAD Gene (5343, 59.5%), DAVID (5254, 58.5%) and Onto-Translate (4786, 53.3%) (Fig. 4.8(c)). A
total of 945 (10%) of the IDs were exclusively converted by AbsIDconvert.
In the third conversion, 1000 randomly sampled human Affymetrix® GeneChip HG-U133 Plus
2.0 probesets were converted to Agilent Cgh44b probes (Fig 4.8(d)). This type of cross-platform
conversion is important in meta-analysis studies where results are drawn by integrating and analyzing
data from a number of independent studies/platforms. As this type of conversion is available only in
Synergizer, we compared the conversion results of this tool with AbsIDconvert. Synergizer converted
183 whereas AbsIDconvert converted 162 probesets. The reason for the small number of conversions
is primarily due to the design differences of the probes on these chips. Two questions required
deeper investigation: 1. Why was AbsIDconvert not able to convert 64 Affymetrix® IDs that were
successfully converted by Synergizer; and 2. Are the 43 conversions exclusive to AbsIDconvert valid?
To answer these, we extracted the design annotation of all the Affymetrix® GeneChip HG-U13~{
Plus 2.0 probesets provided by Affymetrix's NetAffx [148] along with the design annotations for the
Agilent Cgh44b probes supplied by Agilent [149]. These provided the individual locations of each
probe on the hg19 genome, thereby enabling investigation of the interval separation between the
probesets.
In order to examine the 64 probesets converted by Synergizer but not by AbsIDconvert, the
genomic location(s) of the Affymetrix® probesets were compared to the genomic locations of the
Agilent probes. Fifty-six (out of 64) of the probes are separated according to their genomic locations
and do not overlap at all. This separation ranges from 75 to 418,671 BP with a median separation
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of 4,736 bases. Further analysis determines that these all lie in the regions between the individual
probes of the respective probesets and therefore have no shared sequence identity.
Most of the ID converter tools including Synergizer map the genetic entities (probes, probesets)
spanning tens of bases to an intermediary such as Ensembl that is at a coarser granularity spanning
a few kilobases with possible intronic regions. 'Vhile performing conversions, these tools only use the
probe annotation, disregarding the actual sequence information. The above false positives provided
by Synergizer are likely the result of ignoring the sequence level information as the two types of
probes actually span different genomic intervals.
Next we considered conversions found exclusively by AbsIDconvert. Based on the official annotation from NetAffxTM, we found that intervals for all 43 Affymetrix® probesets actually contain
or overlap the converted Agilent probes with a mean overlap of 56.43 bases. Considering that most
of the Agilent probes are 60 bases long and an Affymetrix® probeset contains overlapping 25 bp
probes, this indicates most of these Agilent probes are contained in the Affymetrix® probeset region.
These probesets were checked at the probe level and it was determined that these converted Agilent
probes overlap with individual Affymetrix® probes to some extent, or are completely contained with
a mean overlap length of 38.70 BP. We are not sure why Synergizer was unable to convert these

4~~

probes; however, the official annotation confirms these annotations and bolsters our confidence in
the power and accuracy of our sequence based ID conversion.

4.7

Case studies

Three illustrative case studies were explored to demonstrate the capabilities of AbsIDconvert. The
first case study considers sequence-based mapping of identifiers in a comparative genomics analysis
of organisms involved in malaria; the second examines remapping of probes to annotations within
and across species using a historical cDNA platform from Incyte; and the third identifies Ensembl
transcripts mapped by Agilent and Affymetrix® arrays.
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4.7.1

Case study 1: Comparative genomics: plasmodium mapped to human and Anopheles gambiae

Recent studies have surveyed the role of both host and pathogen genetic variability to determine molecular signatures for host-pathogen interactions [150]. While the interactions between
a pathogen and its host are often mediated by the host immune system responses to the pathogen,
host-pathogen relationships theoretically have the potential to create a metagenomic environment
whereby the total transcript orne is contributed by both the host and pathogen genes. In some
cases, such as Neisseria meningitidis, a direct interaction between host and pathogen genes has been
demonstrated [151]. As an illustrative example, it might be possible that shared sequence similarities between pathogen and host genes play a role in host gene regulation via pathogen genes and
gene products that provide additional promoter sites, miRNA targets, and binding motifs similar to
those found in the host. To test the feasibility of this possibility in the context of malaria, we used
absIDConvert to identify coding sequences identical between the PF and PV species and the human
and anopheles genomes.
Plasmodium is a parasite responsible for causing malaria in humans primarily in tropical and
sub--tropical areas. About 3.3 billion people are at risk of this disease, leading to 250 million malaria
cases and one million deaths worldwide every year (http://www . who. int/features/factfiles/
malarial). Altogether four Plasmodium species are responsible which are carried by the female

Anopheles gambiae mosquito. Plasmodium Jalciparum (PF) and Plasmodium vi vax (PV) are the
most common, with PF being the deadliest.
Coding sequences for each gene for these two species were downloaded from the PlasmoDB
website (http://plasmodb . org/) [152]. The total number of coding sequences in PF and PV were
5,524 and 5,435 respectively. Sequences for each of these genes were then fragmented into 50 basepair (BP) long sequences with an overlap of 25 BP. The fragmented sequences were given a unique
name by attaching a numerical suffix onto the gene name that denotes the order of appearance in the
gene sequence. These fragmented sequences were analyzed using AbsIDconvert by selecting default
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Figure 4.9: (a). Number of gene fragments from PF and PV that overlaps with at least one gene from

Anopheles gambiae and Homo sapiens. (b). Corresponding genes in Anopheles gambiae (AnoGam2)
and Homo sapiens (hg19) that were mapped by gene fragments from PF and PV.

parameters including no mismatch while aligning to the Anopheles gambiae (AnoGam2) and Homo

sapiens (hg19) genomes (Fig. 4.9).
A total of 75 gene fragments from PF (PF JIg19 in Fig. 4.9(a)) had an exact sequence match
to 692 human genes (PF JIg19 in Fig. 4.9(b)). For PV, the aligned number of gene fragments and
corresponding genes were 17 (PV JIg19 in F ig. 4.9(a)) and 340 (PV JIg19 in Fig. 4.9(b)), respectively. These numbers indicate that the gene fragments align to multiple locations on the human
genome. Among genes that were mapped from PF and PV gene fragments, a total of 134 genes were
common. When the same gene fragment sequences from PF and PV were aligned to the Anophe-

les gambiae genome (AnoGam2), a total of 99 (PF ...AnoGam2 in Fig. 4.9(a)) gene fragments from
PF were mapped to 87 (PF ...AnoGam2 in Fig. 4.9(b)) different genes, showing that the correspondence between the gene fragments and genes is largely one-to-one. These numbers for PV were 12
(PV...AnoGam2 in Fig. 4.9(a)) and 31 (PV...AnoGam2 in Fig. 4.9(b)), respectively.
A more detailed analysis of the genes identified using ontological information indicates a significant enrichment in cell adhesion processes (Table 4.6). These are present in the GO terms 'cell-cell
adhesion' (and others), but also implied by the large number of terms regarding neuronal a..'{onogenesis and synapse formation, which require specific regulation of cellular adhesion. While purely
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speculative at this point, it is possible these plasmodium genes interact with the human host to help
sequester human erythrocytes in small blood vessels which aids in the invasion plasmodium into the
immune system [153]. While benchtop analysis of these genes is needed to determine if the "feasible"
actually occurs, it is clear that analysis using AbsIDconvert has identified, via cross-species analysis, a limited set of genes that can be further interrogated for understanding the malaria-related
pathophysiology, including the process of plasmodium incorporation into erythrocytes.
Table 4.6: Significantly enriched (p-value < 0.001, number of genes

~

2) Gene Ontology biological

processes for the P. Jalciparum and P. vivax genes.
GO ID
GO:0048639
GO:005186S
GO:OOO7417
GO:0010559
GO:0043062
GO:00:U290
GO:OOS0772
GO:0007268
GO:00071.56
GO:0048745
GO:OOO8038
GO:0071702
GO:0010827
GO:0016337
GO:0045725
GO:00080:17
GO:0010907
GO:004S913
GO:0010676
GO:0030036
GO:0030029

4.7.2

Description
positive regulation of developmental growth
protein autoubiquitination
central nervous system development
regulation of glycoprotein biosynthetic process
extracellular structure organization
retinal ganglion cell axon guidance
positive regulation of axonogenesis
synaptic transmission
homophilic cell adhesion
smooth muscle tissu(' development
neuron recognition
organic substance transport
regulation of glucose transport
cell-cell adhesion
positive regulation of glycogen biosynthetic process
cell recognition
positive regulation of glucose metabolic proc{'ss
positive regulation of carbohydrate metabolic process
positive regulation of cellular carbohydrate metabolic process
actin cytoskeleton organization
actin filament-based process

list Membership
pFai
pFai
pFal
pFal
pFal
pFal
pFal
pFal
pFal
pFal
pFal,pViv
pViv
pViv
pViv
pViv
pViv
pViv
pViv
pViv
pViv
pViv

pFal.Pvaluc
0.0002a
0.000611
0.000749
0.0005:14
0.000896
0.000729
0.000671
9.63E-005
2.90E-00S
0.00097
0.000611
0.358064
0.15634
0.002316
0.316458
0.041274
0.486254
0.561654
0.S61654
0.13:1792
0.099:!08

pViv.Pva.iue
0.078421
0.310842
0.052751
0.189699
0.056366
0.020543
0.108078
0.0044:17
0.00181
0.211";514
2.71E-005
0.000932
0.000705
0.00061S
0.000806
0.000425
0.000312
0.000731
0.000731
8.55E-00S
2.74E-005

Case study 2: Reinterpretation of prior datasets

Annotations used for DNA microarray studies quickly become out-of-date as more knowledge
emerges about a species' transcriptome. In addition, there are instances where one microarray
platform may be used to measure gene products from a comparative species. For example, Incyte arrays spotted with human ESTs have been used to query gene expression levels in mouse
and/or rat, based on the assumption that the human ESTs would bind to and provide measurements of the corresponding gene in rodents [154-156]. Using the original EST sequences spotted
on the array from these studies, we sought to verify the current annotations of the ESTs, and also
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determine which rodent genes should bind the ESTs based on sequence alignment to the human ,
mouse , and rat genomes. Original EST sequences were found by searching two sources using the
Incyte IDs supplied on the chip. The first source was the NCBI EST database, using a search
string composed of IMAGE: and the Incyte clone ID number (identifies clones generated from the
IMAGE consortium sequencing project). The second source was the Open Biosystems database
(http://www.openbiosystems.com/).using a search string composed of LIFESEQ and the clone

ID number. In some instances, multiple EST sequences were returned for each clone ID . A total
of 8,392 sequences were downloaded and aligned to the genomes of human, rat, and mouse using
AbsIDconvert with the default BLAT settings. The genome wide best alignment was found for
each probe by considering only those alignments falling within 5% of the maximal alignment score
(Fig. 4.10(a)) . Corresponding to each of these aligned coordinates, overlapping Entrez IDs were
found for all three organisms. Out of the 7,095 human Incyte IDs which had corresponding genomic
interval(s), 4,155 have at least one human Entrez ID associated with them. This number was 2,081
(out of 3,368) for mouse and 1,438 (out of 2,776) for rat (Fig. 4.1O(b)).

(a)
Figure 4.10: (a). Number of Incyte IDs mapping to the human , mouse and rat genomes within
5% of the maximum alignment score. (b). Incyte IDs with at least one Entrez ID found using
A bsIDconvert.

Homologous genes can be compared across species using NCBl's Homologene resource [157] when
gene names are known. However, if sequence information is available, it would be best to use that
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sequence information to determine if homology exists based on sequence conservation, particularly
in cases where probes of known sequence are being used to measure a specific gene, such as in DNA
microarrays or in-situ hybridization. Both methodologies were applied to the Incyte array used
in [154-156].
For the Homologene based comparison, all of the Incyte IDs that map to at least one Entrez
ID using AbsIDconvert were used to determine if a homologous gene exists, and if so, if there are
corresponding entries for each of the species studied. Similarly, for those Incyte probes matching
at least one Entrez ID, the sequence was used as a query into each of the other species using
AbsIDconvert to determine if the probe maps to and overlaps an Entrez ID in a cross-species sense.
As Table 4.7 indicates, using the Homologene conversion alone yields a high number of homologs
(82% - 88%); however, using the sequence level information, it can be seen that a much lower
percentage of probes (19% - 74%) actually map to known Entrez gene regions in the other species.
These demonstrate that only a small number of the probes on the array should be utilized for cross
species comparisons.

4.7.3

Case study 3: Meta-analytic studies across platforms

Meta-analysis enables the integration of many different experiments with a common research hypothesis. However, high-throughput -omies meta-analyses are hindered due to the heterogeneity
of DNA microarray array designs (length and location of probes), data acquisition, analysis, and
inter- and intra-study variability. Therefore, many meta-analyses use the same species or even the
same array platform to mitigate some of these heterogeneities. However, many studies do still attempt to perform cross-platform and inter-species meta-analyses, and tools such as AIL UN (Array
Information Library Universal Navigator) [158], A-MADMAN (Annotation-based microarray data
meta-analysis tool) [159], and LOLA (List Of Lists Annotated) [160] enable cross-species metaanalysis using Entrez ID, gene symbol or other IDs as a conversion intermediary. AbsIDconvert
can perform cross-platform / -species analysis efficiently using the sequence based approach. We
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Table 4.7: Comparison of Homologene and sequence based homologs.

00

Ql

Organism
Human
Mouse
Rat

mappedt Entrez
4155
7095
2081
3368
2776
1438

t

Homol§
3854
1872
1263

Human (Hom)
-

1794 (86%)
1210 (84%)

Mouse (Hom)
3648 (88%)
-

Rat (Hom)
3401 (82%)
1715 (82%)

1222 (85%)

-

Human (Seq)
-

1002 (48%)
806 (56%)

Mouse (Seq)
1002 (24%)
-

Rat (Seq)
806 (19%)
1064 (51 %)

1064 (74%)

-

mappedt:Number of probef! mapped to Genome: Entrez+:Mapped probes with Entrez 10: Homol§: Probes with Entrez 10 as well as Homologene 10: Hom: Homologene Based Homologs; Seq: Sequence Based Homologs

determined using AbsIDconvert.

previously demonstrated that AbsIDconvert efficiently and accurately converted Affymetrix® HG_U133Plus2.0 probes into Agilent Cgh105a probes, among other types of conversions.
To determine how comparable two microarray studies using different array platforms on a common organism could be, Affymetrix® HG_U133Plus2.0 and Agilent Cgh105a probe sequences were
mapped and converted to corresponding human Ensembl transcripts using the default AbsIDconvert
parameters. For the Affymetrix platform, 423,815 out of 603,158 probes were mapped to one or more
transcripts, with 94,713 of the total Ensembl transcripts (173,742) being mapped (Fig. 11). This
leaves 79,029 Ensembl transcripts that were not mapped by any Affymetrix® probes. For Agilent,
27,184 (out of 99,026) mapped to 60,829 Ensembl transcripts. 79,029 (45% of the total) Ensembl
transcripts do not have any mapped Agilent Cgh105a probes. The number of shared Ensembl transcripts between platforms was surprisingly small (46,308), indicating that each platform appears to
have probe specific subsets of Ensembl transcripts. The number of Ensembl transcripts not probed
by either platform was surprisingly large. This appears to be due to a lack of probes designed to
bind those Ensembl transcripts, as the majority of unmapped transcripts are much shorter than
those that are mapped (Fig. 4.12). As Fig. 4.11 illustrates, 46,308 transcripts should be directly
comparable between Affymetrix® HG_U133Plus2.0 and Agilent Cgh105a, while a large number of
transcripts are not available in one or the other (or both) platforms.

Figure 4.11: Ensembl transcripts mapped by Agilent Cgh 105a and Affymetrix® HG_U133Plus2.0
probes.
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Figure 4.12: Exonic lengths of Ensembl transcripts mapped/ unmapped by probes

4.8

Conclusion

A bsIDconvert is the only known gene ID conversion tool based on genomic coordinates / intervals of
which we are aware. This is a novel and important contribution in the realm of gene ID conversion
due to the large variety of genetic entities in current use by biologists, the need to convert between
them , and the fact t hat most biological entities (nucleic acid, protein entities etc.) have an associated
sequence. Mapping of the entity sequence to a reference genome sequence provides the concomitant
genomic interval that allows determination of other entities that have overlapping genomic intervals.
The interval basis of AbsIDconvert provides ease of flexibility with respect to any additions,
deletions or updates of the underlying objects, requiring only adding of intervals, removing intervals,
or modifying the intervals themselves , respectively. This makes it possible to easily keep the structure
updated as the current state of biological knowledge changes. A major update is only required
when the underlying genome changes, a fairly rare occurrence for most organisms, especially when
compared to how often other genomic databases are modified.
These intervals also allow easy discovery of genetic entities that only partially overlap with
queried IDs / intervals, or that are within a specified distance nearby. More frequently, researchers
are interested in those genes that are near specific genomic intervals corresponding to various types of
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genetic control elements such as transcription factor binding sites, enhancers, untranslated regions,
and hyper / hypo methylated regions.

AbsIDconvert makes it easy to find those entities that

overlap or lie nearby regions of interest. With the incorporation of a sequence mapping algorithm,
AbsIDconvert integrates the determination of genomic intervals for any supplied sequence, making
it possible to easily find and convert between IDs from any platform and organism, such as the
examination of correspondence of the human EST clones with rat and mouse genes (case study 2)
and of plasmodium and human genes (case study 1). We do not know of any other system that can
easily accomplish these types of analyses.
AbsIDconvert can greatly facilitate the work of those who are involved in meta analyses studies.
When comparing studies where either the species and / or platform varies, this methodology will
have clear advantages over others as it is based on common genomic coordinates.
The use of an interval tree structure makes it possible to perform large conversions quickly and
efficiently. This method is efficient while dealing with genomic intervals and has a significant advantage over other methods such as relational databases. Although theoretically limited by working
memory, none of the interval trees generated and used by AbsIDconvert require more than 300MB
of RAM on the deployed server, with the majority being rather small in size (less than 10 MB). If
the data cannot fit into main memory, a method such as that proposed by Arge et al. [102] [103]
can be used that maintains the interval tree in secondary memory efficiently.
AbsIDconvert is provided as a web page at http://bioinformatics.louisville.edu/abid/,
and is also available as a virtual machine for those wishing to run a local instance. Future work will
include providing command line access, a RESTful interface, and modifying the interface to utilize
a workflow management tool for genomic data such as GALAXY, where the primary data units are
genomic sequences and intervals.
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CHAPTER 5
A HEURISTIC ALGORITHM FOR DETECTING

INTERCELLULAR INTERACTIONS
5.1

Introduction

Cell--cell interactions are important aspects of many biological processes. Examples include migratory processes (e.g., immune cell transvascular migration, nervous system development, and cancer
metastasis), binding processes (e.g., oocyte implantation and leukocyte tethering and rolling), induction processes (e.g., stem cell generation and floor-plate or roof-plate modulation of neuronal fate),
and adaptation/plasticity processes (e.g., neovascularization, axonal regeneration or sprouting, and
sequestration of cancerous or infected cells). Chemical factors released by the skin both constitutively and in response to various stimuli activate receptors expressed by the sensory axons providing
innervation of the skin [161]. This activation can initiate a signaling process which ultimately influences neuronal structure and/or function by affecting transcription and translation. The structural
nature of the nervous system is unique in that for a single cell the location of the initiation of the
signaling cascade (skin) and the location of transcription/translation (sensory neuron cell body in
the dorsal root ganglia between vertebrae) can be separated by great distances, in cases of large animals up to many meters. Thus, the interaction site and the transcription/translation site represent
different tissue samples, and are run separately for proteomic and transcriptomic analyses. Information regarding intercellular interactions, particularly when the interacting elements are represented
in separate samples, is generally not efficiently/accurately extracted with existing analytical tools,
but may be extracted by examining the list of regulated genes/proteins against databases of known
molecular interactions.
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Figure 5.1: Evidence view of BRCA2 protein interactions from the STRING protein database.

Given a list of relevant genes or proteins (here, the concept of gene and protein is used interchangeably) reacting to a given condition, it is a simple process to find all interactions within the
gene list and with other genes using known interaction network data. As an example, Fig. 5.1 shows
the interaction network of BRCA2 from the STRING [1621 database. BRCA2 is connected to many
genes or proteins. These interactions may be direct or indirect through a transitive relationshlp.
For example, BRCA2 is connected directly to BRCA1 and indirectly to ATM via BRCAl. As the
number of genes in the list increases, the complexity of the network generated will also increase
exponentially.
It has been widely established that cell-cell interactions are mediated via protein- protein (gene-

gene) interactions. Having lists of genes that are differentially expressed from two different tissues, it
is of interest to determine how the expression of genes in one tissue might influence gene expression
in another tissue. The influence may be positively correlated (up- regulation of gene A in tissue 1
up- regulates gene B in tissue 2) or negatively correlated (up- regulation of gene A in tissue 1 downregulates gene B in tissue 2) . The signal may be carried from one tissue to another via a number of
intermediate proteins. Therefore, it would be advantageous to find all possible interactions between
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two sets of genes with up to n-intermediaries. Finding all possible paths leading to these interactions
is computationally intensive especially when the number of interactions is on the order of hundreds
of thousands as each of the nodes may interact with hundreds of other nodes.
To solve this problem, a heuristic method is developed that combines the" Backtracking Algorithm" and a novel concept of exclusion vector (EV). The EV supports two functions: (1) restricting
the interaction search space at each iteration; (2) restricting the search space based on defined properties of the proteins. In this work, the location of the proteins according to the cellular component
annotation in the Gene Ontology (GO) [82] is used. This method can be readily applied to separate tissue samples that interact, such as neuronal cell bodies and their target tissues, or specific
cell-types separated from their native tissue (for example, laser-capture or FACS).

5.2

Interaction databases

To find the pathways or interactions in which a particular gene is involved, we need to search into
the available interaction databases. There are many interaction databases publicly available such as
PathwayCommons ( wwv. pathwaycommons. org), STRlNG [162]' STITCH [163] [164]' HaPPI [165],
InPrePPI [166], KEGG [111], BioCarta, GenMapp [167], BioGRlD [168], MINT [169] and IntAct [170]. A detailed review pertaining to the protein-protein interactions and pathway databases
and visualization software can be found in [171].
PathwayCommons provides a common platform to access pathway information from multiple
sources represented in a common format. It collects, stores and integrates pathway and interaction
information from various publicly available databases. These interaction include biochemical reactions, complex assembly, transport and catalysis events, and physical interactions involving proteins,
DNA, RNA, small molecules and complexes. As of February 2012, it contains 442,182 interactions,
1,668 pathways and 86,282 physical entities spanning across 414 organisms. This database can also be
accessed programmatically via a web service API. For example, the command get-pathways retrieves
all pathways involving a particular physical entity such as BRCAl. PathwayCommons import data
from the databases which store the interaction data in BioPAX format ( http://wwv . biopax. org/).
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BioPAX is a common standard format to enable integration, exchange, visualization and analysis of
biological pathway data.
STITCH (Search Tools for Interaction of Chemicals) integrates data from different sources such as
bench-top experiments, databases and literature to mine known and predicted interactions of chemicals and proteins. The scoring method adopted gives more weight to manually curated interaction
while a relevance score is attached to the interactions that are based on experimental information. To
search for interactions in chemical databases, STITCH uses the SMILES (Simplified Molecular Input Line Entry System) (www.daylight.com) strings and the InChI(IUPAC's International Chemical
Identifier) codes. As of May 31 st , 2012, STITCH contains interaction for over 300,000 small molecules
and over 2.6 million proteins in 1,133 organisms (http://stitch.embl.del).

The interaction

database as well as the query results of interactions are publicly available to download from http:
Iistitch.emblode/. STRlNG (Search Tool for the Retrieval of Interacting Genes/proteins) is a
similar database of physical and functional interaction of proteins. It relies upon the manually
curated data from primary interaction databases such as BioGRID, IntAct, MINT, and BIND and
combines it with the information extracted from pathway databases such as KEGG, EcoCyc and Reactome. STRING also incorporates protein-protein prediction algorithms. The database currently
conains 5,214,234 proteins across 1133 organisms ( http://string . embl. del).
HAPPI (Human Annotated and Predicted Protein Interactions) is a comprehensive web-based
resource for exploring human protein interactions.

It integrates data from various interaction

databases and stores them in a relational database. It also incorporates a unified scoring scheme
to calculate the quality/confidence of the protein interaction results by giving them a star rating ranging from 1 through 5 [165].

As of November 2009, this database contained informa-

tion for 13,601 proteins and almost 1.3 million PPI (http://discern . ui ts. iu. edu: 8340/HAPPI/).
BioGRID (http://thebiogrid . org/) is another online interaction database that searches over
30,287 publications for 461,097 raw protein and genetic interactions from major model organism species (as of February 2012). The new curated interactions are updated monthly. The interaction data are freely available to download in tab delimited text and PSI-MI XML which
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are HUPO's standard to store interactions. IntAct provides freely available database system for
containing information(as of February 2012) for 60,993 proteins and over 291,835 binary interactions (http://www.ebi.ac . uk/intact/).

5.3

A vailable algorithms

There are a number of methods that integrate information from different interaction databases to
predict gene functions. GeneMANIA[172] [173] is one such tool that integrates multiple functional
association networks and predicts gene functions. There are a few approaches that address the issue
of intercellular interaction using the available interaction network information. In one study, Tarca

et al. used signaling pathway impact analysis to gain biological insight from two set of genes [174].
Kirouac et al. [175] studied the intercellular and intracellular networks in a stem cell derived, hierarchically organized tissue by analyzing cultured human umbilical cord blood progenitors. They
showed that secreted factor-mediated intercellular communication networks regulate blood stem
cell fate decisions. However, in none of these studies has a general method to determine possible
intermediaries in intercellular signaling been proposed.

5.4

Methodology

A naive algorithm and the proposed heuristic algorithm are outlined here to solve the above problem.
The gene lists are assumed to be from two different tissues, Tl and T2 and may be subsets of much
larger lists, selected using some criteria such as the level of expression of individual genes. One
protein may interact with another either directly or indirectly via a number of other proteins. One
direct interaction between two proteins is called a hop.

5.4.1

NaIve algorithm

The naive approach to find all possible interactions between two sets of proteins is to take the protein
list Tl as a seed into the interaction database to find all possible interactions. Using the targets from
the previous step as the source nodes, a new set of interactions are found. This step is repeated up
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Figure 5.2: Nalve approach to find gene interaction.

to h hops iteratively. Fig. 5.2 illustrates the nalve approach where a gene or protein in tissue Tl
may interact with other genes or proteins, and those in turn interact with others and so on, finally
reaching genes in tissue T2. If the initial gene set is {A , B} , then using the interaction database
it can be determined that these two genes in turn interact with four genes {X, Y , Z, W} where A
interacts with {X,Y} and B interacts with {X, Y , Z, W} as shown by the edges in Fig. 5.2. Some of
these genes may be found to be expressed in the same or different cellular components such as the
nucleus, cytoplasm or cellular membrane. Gene X belongs to the same cellular component as {A, B}
whereas genes {Y, Z, W} belong to different cellular components. Fig. 5.2 shows the network after
two degrees of separation or hops (h) in tissue T 1 . In this example, gene A interacts with X and
X interacts with P, resulting in two hops to traverse from A to P . The number of hops between a
pair of nodes from one tissue to another may vary. To address this concern, the interactions may be
checked for a number of hops ranging from 1 through h. The pseudocode for finding all interactions
using a nalve algorithm is shown in Algorithm 2. In this example, intxnDB is a PathwayCommons
interaction database in simple interaction file (SIF) format where each entry represents an interaction
from a source ('from') node to a destination ('to') node with each node being a gene or protein.
Although there is no directionality in the actual interaction data, directionality is explicitly added
by appending a symmetric property to the data. In this case, if entry A interacts with B (A ,B) then
B interacts with A (B,A) is added into the set of interactions.
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Algorithm 2 Naive Algorithm for Finding all Interactions.
1:
2:
3:

4:

5:
6:

7:
8:
9:
10:
11:
12:
13:

14:
15:

procedure ALLINTXNNAlvE(input, h, int:rnDB)
n ~ length(input);
t> input contains all start nodes (A and B in Fig. 5.2)
hops ~ 1
repeat
t> for each input find all direct interactions
for j ~ l,n do
node = input[j]
for k ~ l,lenlntxnDb do
t> for each input find all direct interactions
t> Add intxnDB[k, 'to'] as child of node;
if node = intxnDB[k, 'from'] then
end if
end for
end for
t> input is now all the children attached in the previous step
n = length(input)
hops = hops + 1
until hops::; h
end procedure

Starting with n initial nodes (A and B are two initial nodes in Fig. 5.2), finding all possible
interactions requires searching for all interactions of a gene or protein and incrementally building the
interaction network. Taking the rat interactome as an example (511,408 interactions and 3,778 nodes
as of April 18th , 2011. Average interactions per node

=

136), and assuming that the interactions

are represented as a tree structure, on average each of the nodes at the root level has 136 children.
Each of these children at the first level, on average, has 136 children in the second level, and so on.
Finding all the interactions in such a way is an intractable problem as the run time for the algorithm
will be O( n * 136 h * m) where h is the maximum number of hops (levels in tree example) required and
m is the total number of interactions in the intxnDB. Using a binary search to find interactions in
the intxnDB will take O(n

O(n * kh

5.4.2

* log2(m))

* 136 h * log2(m))

time, where intxnDB is the rat interaction data, and

time in general, when k is the average number of interactions for each node.

Proposed heuristic approach

To address the computational issues with the naive approach, a heuristic algorithm is proposed to
find all possible interactions across tissues in an iterative way. The heuristic uses an exclusion vector
(EV) that is updated at each iteration to maintain a list of those nodes that should not be considered
in future iterations. The "backtracking approach" removes in each iteration all those nodes already
used in the previous iterations. This reduces the complexity of the search space as the removal of a
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Figure 5.3: Flow diagram for finding participating nodes and interactions.

single node in 136 - ary tree removes the subtree rooted at that node, thereby reducing the overall
complexity to be directly proportional to the number of participating node p in the final interaction.
A meet-in-the-middle (MIM) concept is used to limit the number of participating interactions by

removing all those nodes that do not lead to MIM nodes. MIM nodes are defined as those nodes
found in common at some place between two tissues when the traversal begins from the set of nodes
from either tissue. Once the common nodes are known , a trace-back can be used to include only
those interactions that lead to MIM nodes, while the rest of the interactions are removed.
The EV can also be used to store a set of nodes that should be excluded from the interaction
calculation. The EV can be initialized with an optional set of nodes that are known not to play
any role in the interaction. A hash table is used for storing the interactions, thereby reducing the
running time to B( n * 136 h * B(l)) in contrast to B( n * 136 h * m) in the nai've approach. The complete
heuristic algorithm is shown as flow diagram in Fig. 5.3 and the steps are explained as follows.

1. Location Awareness: Considering that many proteins are localized to a specific region of

the cell, have different molecular functions or are involved in different biological processes
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that may restrict the possibility of interacting across tissues, a desirable property is to have
some control over which genes are considered. For instance, if it is known that a protein is
restricted to the nucleus and is not going to playa role in some form of direct intercellular
interaction, it is better to be able to exclude (optionally) all those genes that are in the nucleus
and not found anywhere else. One popular source of information for these properties is Gene
Ontology (GO), which contains annotated information concerning the cellular localization of
proteins. Therefore, it is advantageous to populate the EV based on those genes with/without
particular GO annotations as an initial step in the algorithm. However, searching all genes that
are exclusively annotated by a subset of GO annotations may take time {}(n

* m),

where n is

number of genes while m is total number of cell components. In the worst case the complexity
will be {}(n 2 ). This algorithm stores the annotations as bit vectors to allow quick searching of
genes that are annotated with particular GO terms in time {}(n).
Table 5.1: Occurence matrix using cellular component information for a sample gene set.

swissProtID
055007
Q9ES40
POR050
BOBNC4
088407
BOBNCR
Q8K5C2
Q9JM59
035049

GeneName
Park2
Arl6ip5
Gjal
Agxt212
Faim2
Garnll
Park2
Kenip2
Smpd3

NUCLEUS
GO: 5634
1
0
0
0
0
1
1
0
0

CYTOPLASM
GO: 5n7
1
1
1
0
0
1
1
1
0

MITOCHONDRION
GO: 5739
1
0
0
0
0
1
0
0
0

PLASMA MEMBRANE
GO: 5886
0
0
1
0
1
0
1
1
1

CELL JUNCTION
GO: :10054
0
0
1
0
1
0
1
0
0

SYNAPSE
GO: 45202
0
0
0
0
1
0
1
0
0

Given a set of gene-GO annotations, an occurrence vector (OV) is generated for each gene
with all GO annotations in a given sub-ontology (biological process, molecular function, or
cellular component (CC)). An example occurrence matrix (OM) is shown in Table 5.1. The
table contains six cell components with GO identifiers 5634, 5737, 5739, 5886, 30054, 45202.
The OV for all the genes will be generated once and can be used later. For instance, the OV for
the gene park2 (swiss Prot ID 055007) is {111000} with 0 indicating absence and 1 indicating
the presence of the park2 gene product in the corresponding CC. A list of GO identifiers
are supplied. Genes that are exclusively annotated with those identifiers or their subsets are
selected to serve as candidates for the exclusion vector. For instance, if the supplied GO CC
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IDs are {5737, 5886}, then genes are exclusively annotated with 5737 or 5886 or both. The
OV corresponding to the query will be OVq = {0101O0}. For each gene i, if OVq Q9 OVi = 0
then gene i is included in the initial set of exclusion vector EVI . Here, the symbol Q9 can be
defined as:

where Xi represents the bitwise NOT of Xi and· represents the bitwise AND operation. In
Table 5.1, only Q9ES40, BOBNC4, Q9JM59, 035049 qualify to be included in EVI while the
rest of the genes are removed as they are either not annotated with 5737 or 5886 or they
are also annotated with additional GO identifiers. Finding genes using the OV will require

B(n) time as the OV of each gene is compared with the OVq using a bitwise operation. It
should be noted that, in theory, any gene annotation data can be used to generate the OV and
subsequently used to populate the EV at the initial step of the algorithm.

2. Initial Step: The complete interaction database and two sets of genes (set of nodes from TI
and T 2 ) between which interactions are to be determined are given as input. A hash table

(hashEdgeList) is generated from the edge list. An optional EVI from the previous step (EVI
is empty when location awareness is not taken into consideration) is also converted to a hash

(hashEV). For each source node a lookup is performed on hashEdgeList adding all those edges
with targets not in hashEV. Once the interactions for all the nodes in the set are found then
one hop (pass) is completed (Fig. 5.4a-b).
3. Iterative Step: In the iterative step, the EV is first updated. In the ith iteration, EVi is
populated as follows:

EVi

= EVi--1

U srCi-l,

i :::: 2

The EV at each step is a union of all the nodes in the EV and the source nodes (src) in
the previous step (Fig 5.3). The EVi is then converted into a hash table (hashEV). Using
the interactions from the previous iteration, hashEV and hashEdgeList, the interactions for
each source node not in hashEV are found. This step is repeated for the required number
of hops or until no more interactions can be added to the system. This will generate all
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valid interactions considering the location-aware algorithm combined with the heuristic that
iteratively populates the EV.

Algorithm 3 Heuristic algorithm to generate all participating interactions.
procedure HEURISTIC (geneList, hashEV, edgeList)
hashEdgeList = hash(edgeList[,' from']' edgeList[,' to'])
- - - - Initial step - - - - 3:
intxn = ¢
/ * Store interactions in present hop. */
4:
for i +-- 1,length(geneList) do
5:
src = geneList[i]
6:
tgts = hashEdgeList[[src]]
7:
if tgts != NULL then
8:
for j +-- 1,length(tgts) do
9:
tgt = tgts[j]
10:
if hashEV[[tgt]] == NULL then
11:
Add (src, tgt) to the intxn
12:
end if
13:
end for
14:
end if
15:
end for
- - - - Iterative Step
16:
loop = TRUE;
17:
while loop do
18:
src = intxn[,' tgt']
19:
if length(src) :::; 0 then
20:
loop == FALSE
21:
break
22:
end if
23:
EV = EV U src;
24:
hashEV = invert(hash(l : length(EV), EV));
25:
for i +-- 1, length( src) do
26:
S = src[i]
27:
if hashEV[[sll != NULL then
28:
tgts = hashEdgeList[[srcll
29:
if tgts != NULL then
30:
Add (src, tgts) to the intxn
31:
else
32:
Exit
33:
end if
34:
end if
35:
end for
36: end while
l!ihd procedure
1:

2:

Pseudocode for the heuristic algorithm is given in Algorithm 3. These interactions are only
generated once for a particular set of differentially expressed nodes. Line 2 builds a hash table.
Lines 3 to 15 represent the initial step. Lines 16 to 30 iteratively find the interactions.
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Figure 5.4: Steps in the construction of an interaction network using the heuristic algorithm.

4. Steps 2 and 3 are performed for both gene sets under consideration to find all possible interactions fulfilling the criteria. Fig. 5.4(c) shows two hops of interactions from Tl while Fig. 5.4(d)
shows three hops of interactions from T 2 .
5. The MIM nodes are determined, and the edges and nodes that do not lead to MIM nodes are
removed. Fig. 5.4(e) shows the interaction network after performing this trace- back. The size
of resulting interaction graph is smaller than the one with the full set of interactions. The
inter acting proteins between the tissues can then be viewed in a graph visualization package
such as Cytoscape [176] [1 77].

5.5

Finiteness and completeness of the heuristic approach

The proposed heuristic algorithm is finite, meaning that the algorithm will come to a halt after
performing a certain number of steps. T he EV is populated at each iteration and its size increases
after every iteration. T he algorithm converges and ceases when no new nodes can be added into the
interaction . At this m oment, the EV contains the same set of nodes as those in the network itself.

In contr ast, the nai"ve algorithm does not contain any criteria of finiteness and a maximum number
of hops (h) must be supplied to the algorithm to force completion. T he EV in the it" iter ation are
updated as below:

EVi = EVi- l U STC; -
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l ,

i ~ 2

Inclusion of all the nodes in

srCi-l

in the equation is guaranteed to include all the back edges and

correctly include all the nodes and interactions. The initial step of the algorithm in Fig. 5.3 applies
the EVon the target nodes instead of source nodes (iterative step) to keep all nodes that are nuclear
and in the geneList as the cell interaction may generate from the nucleus and go out to some other
cells.

5.6

Results

The following results all use the interaction database for rat from PathwayCommons database. This
interactome contains a total of 511,408 interactions with 3,778 nodes as of April 18 th , 2011. Each
node on an average contains 136 direct interactions with other nodes. Finding interactions using
the naive approach presented in Algorithm 2 quickly becomes intractable. For instance, with a
random starting gene set of just 10 initial genes, the first hop for determining interactions takes 3.5
seconds. The second hop takes 5,820, and the third hop does not complete. Therefore, a modified
naive approach was implemented that uses a hash to speed up retrieval of gene interactions for
comparative purposes.
Table 5.2: Comparison of Heuristic and Naive algorithm.

geneList
10
50
100
200
300
400
500

# hops
7
7
6
7
6
5
5

time
10.57
11.26
11.66
11.89
11.76
11.76
11.36

Heuristic
#intxn #nodes
388372
1099
388384
1108
1131
388420
388516
1196
388478
1180
388554
1216
388565
1224

naive using hash
time
#intxn
#nodes
91.78
2714869
1107
83.54
2343199
1153
70.41
1962689
1220
90.92
2376875
1361
75.39
1449
2016790
114.61 2821283
1583
63.93
1674262
1692

The speed-up of the heuristic algorithm versus the modified naive approach with hashing was
computed by taking random gene lists (ranging from 10 to 500 in number of genes) extracted
from the PathwayCommons rat interact orne dataset for both the "from" and "to" gene lists which
conceptually represent different tissue types. The generated gene list size is given in the geneList
field of Table 5.2. An additional input for the number of maximum hops must be supplied for
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the naIve algorithm, as it will otherwise continue adding interactions ad infinitum. For each of
the gene lists, the maximum number of hops used was the number of hops taken by the heuristic
algorithm before completion to provide a fair comparison of the approaches. Since the gene lists
are generated randomly, the number of required hops fluctuates between five and seven as shown in
the Table 5.2. In these examples the EV was used only to remove nodes that had been previously
encountered (Le.

no localization information was included).

As can be seen in Table 5.2, the

number of nodes (i.e. genes) and the number of interactions both remain relatively stable with
the heuristic approach, while the naive algorithm has greater fluctuations. However, the number
of interactions increases substantially in the naIve approach, ranging from four to seven times as
high as the number of interactions found using the EV heuristic. The actual computational time for
generating the respective interaction networks is given in the third column. From these results, the
heuristic approach is anywhere between five to nine times faster than the modified naIve approach,
which could be reduced further when localization is incorporated in the EV.
To further illustrate the applicability of the heuristic algorithm for intercellular signaling, we generated gene lists from different tissues using a publicly available dataset from Gene Expression Omnibus (GEO) [93J (GEO accession GDS1864, http://www.ncbLnlm.nih.gov /sites/GDSbrowser?acc=GDS18
64) containing 62 total samples studying the effects of two antiepileptic drugs (levetiracetam, phenytoin) on the expression of genes in three brain tissues: brainstem, frontal cortex, and hippocampus.
As the drugs are administered to whole animals, it is possible that some of the changes in gene
expression are due to intercellular signaling between the tissues. Differentially expressed genes are
found using empirical Bayes statistics [178J from the Bioconductor [179J limma [55J package with
a p-value < 0.05. The initial gene lists contained 311 and 324 differentially expressed genes for the
frontal cortex and the hippocampus tissues respectively. Up-- and down- regulated gene lists for each
tissues 10gFC > 0.5 for up-regulated, 10gFC < -0.5 for down-regulated genes) were generated for the
comparison of exposure to phenytoin with controls. The interactions between up-regulated genes
in cortex and up--regulated genes in hippocampus are shown in Fig. 5.5. Four hops from the frontal
cortex and three hops from the hippocampus (a total of six intermediate nodes between cortex and
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b

Figure 5.5: (a). Output from Cytoscape showing interactions between the frontal cortex (left) and
the hippocampus (right). (b). Detail of the inset in (a).

hippocampus) are considered here. Nodes (genes) up-regulated in the respective tissue are colored
red, while those that are down- regulated are green. Nodes that are white represent genes that are
either not significantly changed, or are not present on the array. The resulting interaction network
contains a total of 387 nodes (genes) and 2170 interactioDS . This example demonstrates how an
interaction network can be built, and subsequently visualized. Gene location information was not
used in this example. Inclusion of location information and further filtering by an expression cut-off
can significantly reduce the interaction network even further .

5.7

Conclusion

A heuristic algorithm is developed for detecting and predicting intercellular interactions. Considering
the large number of interactioDS this algorithm may serve as a time efficient algorithm to view
interactions between cells. The use of the EV allows location awareness in the interaction in an
efficient manner. The MIM approach further limits the size of the interaction network without
losing any information. The success of the method depends upon the information available in the
respective databases. The more accurate the database , the more reliable the output network will
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be. In this work the edge attributes are not considered, however their inclusion may increase the
confidence in the generated interaction network.
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CHAPTER 6
SUMMARY AND FUTURE WORK

High-throughput techniques in molecular biology are generating high volumes of data waiting to be
understood. A number of databases and software tools have been created to deal with these data.
Oftentimes these databases and their methods for annotating biological entities are independent,
heterogeneous and redundant, yet at the same time contain important information. When combined,
these sources of information can provide a better understanding of a biological system as a whole.
Integration or comparison of these databases is difficult, time-consuming and sometimes impossible
because of the absence of a common platform to compare them directly.
To mitigate issues with conversion among annotations, we developed AbsIDconvert, an absolute
ID conversion tool. This tool is absolute in that it converts annotations to a common source based

on underlying cytogenetic locations. These are represented as intervals with definite start and end
locations, exonic boundaries and lengths. AbsIDconvert uses an efficient interval-tree approach to
store the coordinate-level information and is effective in integrating and comparing heterogeneous
databases.

To our knowledge, AbsIDconvert is the only known gene ID conversion tool based

on genomic coordinates. AbsIDconvert provides ease of flexibility with respect to any additions,
deletions or updates of the underlying objects, requiring only adding of intervals, removing intervals,
or modifying the intervals themselves, respectively.
AbsIDconvert allows flexibility in specifying the overlapping parameters while performing ID
conversion. It can discover partially overlapped IDs / intervals, or those which are within a specified
distance nearby. It also allows discovery of overlapping IDs for a given set of sequences and intervals.
With the incorporation of a sequence mapping algorithm, AbsIDconvert allows the determination
of genomic intervals for any supplied sequence, making it possible to efficiently find and convert
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between IDs from any platform and organism, as demonstrated by the case studies in chapter 4.
AbsIDconvert is also helpful in meta analyses studies such as for performing cross-species and /
or cross-platform studies (case study 3). All these functionalities of AbsIDconvert give it a clear
advantage over other available tools.
AbsIDconvert is currently available at http://bioinformatics . louisville . edu/abid/ with
support to analyze data for 53 organisms, containing a total of over 50 million identifiers. Full
support for additional 1497 bacterial strains are also available.
Since annotations are dynamic, AbsIDconvert also require regular updates; however it is stable
compared to annotation based tools. An update is required when a genome is updated or the DNA
sequence for an entity changes which is not so frequent. Future work includes providing command
line access, modifying the interface to utilize a workflow management tool for genomic data such as
GALAXY, development of fully automated updates, and support for other genomes including plant,
microbial and viral genomes.
Current high-throughput gene expression analyses treat data as if they are obtained from a
single or homogeneous cell population and account only for intracellular interactions. However,

intercellular interactions are equally important and are generally ignored in these analyses. To
account for the interplay between different cells or tissues, we developed a heuristic algorithm for
detecting and predicting intercellular interactions between two populations of interest using publicly
available interaction datasets. Our tractable heuristic algorithm incorporates location awareness at
each iteration using GO ontological cellular component information. An exclusion vector (EV) is
used that efficiently keeps only those interactions that are relevant by restricting the search space
based on defined properties of the genes. An MIM (meet-in-the-middle) criteria is also applied to
further limits the size of the interaction network without losing any information. This method has
been applied to find interactions between frontal cortex and hippocampus tissues as well as skin
and DRG data from Dr. Jeff Petruska's lab. This method can be readily applied to separate tissue
samples that interact, such as neuronal cell bodies and their target tissues, or specific cell-types
separated from their native tissue.
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The success of the method depends upon the accuracy of interaction information available in
public databases. The current method considers all interactions to be equally probable. However,
in an actual biological system, this assumption is limiting. A future improvement to this work
would be to include weight or probability information on each interaction which would lead to more
accurate detection of protein interactions. Using this a priori information, a Bayesian algorithm
can be applied to find the posterior. Additionally, movement of signaling information from one
tissue to another may be systematically determined by considering a hierarchical system based on
localization such as cellular component. For instance, a signal that moves from cell A to another
cell B, will always have to pass from cytoplasm of A, plasma membrane of A, extracellular matrix,
plasma membrane of B and cytoplasm of B. This definitive path may be used instead of MIM nodes
to get more accurate results.
The maintenance of a steady state in complex organisms requires individual cells to perform
activities in a coordinated manner. Ignoring communication of these components while performing
gene expression analysis and assuming that expression is isolated, does not give a complete picture
to biological system as a whole. The systems-based approach proposed in this dissertation overcome
these limitations by taking into account the complete coordinated system. This approach is further
enhanced by AbsIDconvert that considers all annotations to be sequence-based. These methods
will further advance our knowledge of biological systems at a molecular level by looking at the gene
expression data in a more plausible manner.
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Appendix A

SUPPLEMENTARY TABLES

A.I

Entrez IDs converted to GeneSymbol
Table A.l: Entrez IDs converted to gene symbols uniquely by AbsIDconvert.

EntrezID
100505607
100505645
100505920
100505938
100505950
100506044
100506122
100506123
100506130
100506158
100506192
100506272
100506329
100506351
100506452
100506609
100506695

Gene symbol (NCBI)
LOC100505607
LOC100505645
LOC100505920
LOC 100505938
LOCI00505950
LOC100506044
LOCI00506122
LOC100506123
LOC100506130
LOC100506158
LOC100506192
LOCI00506272
LOCI00506329
LOC 100506351
LOC100506452
LOC100506609
LOC100506695

Gene type (NCBI)
miscRNA
miscRNA
miscRNA
miscRNA
miscRNA
miscRNA
miscRNA
miscRNA
miscRNA
miscRNA
miscRNA
miscRNA
miscRNA
miscRNA
miscRNA
miscRNA
miscRNA

100506837
100507153
100507205
100507389
100507581
100507615
100507672

LOC100506837
LOC100507153
LOC100507205
LOC100507389
LOC100507581
LOC100507615
LOC100507672

miscRNA
miscRNA
miscRNA
miscRNA
miscRNA
miscRNA
miscRNA

100529145

TENI-CDK3

miscRNA

100529211

CI7orf61-PLSCR3

miscRNA
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Gene symbol (AbsIDconvert)
LOC100505607
LOC100505645
LOCI00505920
LOC100505938
LOC 100505950
LOCI00506044
LOC100506122
LOC100506123
LOC100506130
LOC100506158
LOCI00506192
LOC100506272
LOCI00506329
LOCI00506351
LOC100506452
LOC100506609
PHF2IB,
LOC100506695
LOCI00506837
LOCI00507153
LOC100507205
LOCI00507389
LOC100507581
LOC100507615
PPARD,
LOC100507672
C170RF106CDK3,
TENl,
CDK3
C170RF61PLSCR3, PLSCR3,
C170RF61
Continued on next page ...

Entrez ID
100630923

100652780
100329135
100505549
100507421
100652826
100303743
100418753
100418754
100418951
100418955
100419014
100419017
100419108
100419553
100419621
100419694
100419779
100419814
100419892
100419951
100419986
100420064
100420177
100420305
100420358
100420741
100420886
100420949
100421028
100421121
100421437
100421471
100421494
100421695
100422265
100422284
100422299
100422510

Table A.I - continued from previous page
Gene symbol (NCBI) Gene type (NCB I) Gene symbol (AbsIDconvert)
miscRNA
LOC100630923,
LOC100630923
LOC100289561,
PRKRIP1
other
LOC100652780
LOC100652780
protein-coding
LOC100329135
LOC100329135
LOC100505549
protein-coding
LOC100505549
protein-coding
LOC100507421
LOC100507421,
LOC100130169
LOC100652826
protein-coding
LOC100652826
pseudo
LOC100303743
WWOX,
LOC100303743
pseudo
LOC100418753
LOC100418753
pseudo
LOC100418754
LOC100418754
pseudo
LOC100418951
LOC100418951
pseudo
LOC100418955
LOC100418955
pseudo
LOC100419014
LOC100419014
pseudo
LOC100419017
LOC100419017
LOC100419108
pseudo
RBMS1,
LOC100419108
LOC100419553
pseudo
LOC100419553
LOC100419621
pseudo
TADA2A,
LOC100419621
LOC100419694
pseudo
LOC100419694
pseudo
LOC100419779
LOC100419779
LOC100419814
pseudo
CUL3,
LOC100419814
LOC100419892
pseudo
LOC100419892
LOC100419951
pseudo
LOC100419951
LOC100419986
pseudo
LOC100419986
LOC100420064
pseudo
LOC100420064
LOC100420177
pseudo
LOC100420177
LOC100420305
pseudo
LOC100420305
pseudo
LOC100420358
LOC100420358
LOC 100420741
pseudo
LOC100420741
LOC100420886
pseudo
WDR35,
LOC100420886
pseudo
LOC100420949
LOC100287225,
LOC100420949
LOC100421028
pseudo
LOC100421028
LOC100421121
pseudo
LOC100421121
LOC100421437
pseudo
ZNF148,
LOC100421437
LOC100421471
pseudo
LOC100421471
LOC100421494
pseudo
LOC100421494
LOC100421695
pseudo
LOC100421695
LOC100422265
pseudo
LOC100422265
LOC100422284
pseudo
LOC100422284
pseudo
LOC100422299
LOC 100422299
LOC10042251O
pseudo
LOC10042251O
Continued on next page ...
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Entrez ID
100422524

100422671
100500934
100507388
100507595
100526736
100533622
100533658
100533661
100533663
100533732
100533846
100631258
100652752
100652792
100505530
100506282
100506342

Table A.I - continued from previous page
Gene symbol (NCBI) Gene type (NCBI) Gene symbol (AbsIDconvert)
pseudo
MLLTlO,
LOC100422524
LOC100422524
LOC100422671
LOCI00422671
pseudo
LOC100500934
pseudo
LOC100500934
LOC100505505,
LOC 100507388
pseudo
LOC100507388
LRRC33,
LOCI00507595
pseudo
LOC100507595
pseudo
LOC100526736
LOC100526736
LOC100533622
pseudo
LOCI00533622
pseudo
LOC100533658
LOC100533658
LOClO0533661
pseudo
LOClO0533661
pseudo
LOCI00533663
LOCI00533663
pseudo
LOC100533732
LOC100533732
LOClO0533846
pseudo
LOClO0533846
LOCI00631258
pseudo
NELLI,
LOC100631258
pseudo
LOC100652752
LOC100652752
pseudo
LOC100652792
LOClO0652792
FLJ45825
unknown
LOC100505530
unknown
LOC100506282
LOClO0506282
unknown
LOClO0506342
LOCI00506342
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Table A.2: Entrez IDs converted to gene symbol by HMS & ID, DAVID and lVIADGene missed by AbsIDConvert.

EntrezID

t--.:J
CN

Gene
(NCBI)

NCB I annotation

type

HMS & ID

-

-

-

-

-

-

-

-

-

-

CPB2-AS1
COL4A2-AS2
FAM91A2
MIR619

miscRNA
miscRNA
miscRNA
miscRNA

replaced withGene ID: 9414
replaced withGene ID: 390831
replaced withGene ID: 100420746
replaced withGene ID: 100418887
replaced withGene ID: 100288486
Not on current assembly
Not on current assembly
Not on current assembly
Not on current assembly

729634

KRT18P26

pseudo

Not on current assembly

KRT18P26

100189058
283486
100131497
401021
729683
100288085
100131004
100131310
100132365
100286906
100289058

TRNAQ9
LINC00567
LOC100131497
LOC401021
LOC729683
DYZ1L5
LOClO0131004
LOC10013131O
LOC100132365
LOC100286906
LOC 100289058

tRNA
unknown
miscRNA
miscRNA
miscRNA
other
protein-coding
protein-coding
protein-coding
protein-coding
protein-coding

Not
Not
Not
Not
Not
Not
Not
Not
Not
Not
Not

TRNAQ9
LINC00567

286750
5374
728795
493620
645128
100507343
100129836
57234
693204

.....

Gene symbol
(NCBI)

-

---

on
on
on
on
on
on
on
on
on
on
on

current
current
current
current
current
current
current
current
current
current
current

assembly
assembly
assembly
assembly
assembly
assembly
assembly
assembly
assembly
assembly
assembly

-

CPB2-AS1
COL4A2-AS2
FAM91A2
MIR619

-

-

-

MADGene

DAVID
DFNA51
PMM2P1
LOC728795
TAGLN2P1
LOC645128

DFNA51
PMM2P1
hCG_1644355
TAGLN2P1
LOC645128

-

-

LOC100129836
LOC100129836
FAM91A2
FAM91A2
MIR619
MIR619
KRT18P19,
KRT18P26
KRT18,
KRT18P26
TRNAQ9
TRNAQ9
LOC283486
LOC283486
LOC100131497
LOC100131497
LOC401021
LOC401021
LOC729683
LOC729683
LOC 100288085
LOC100288085
LOC100131004
LOC100131004
LOC10013131O
LOC10013131O
LOC100132365
LOC100132365
LOC 100286906
LOC100286906
LOC100289058
LOC100289058
Continued on next page ...

!

Entrez ID

Gene symbol
(NCBI)

Gene
(NCBI)

Table A.2 - continued from previous page
type
NCBI annotation
HMS & ID

MIR548B
IGHD20R152B

LOC399839,
HPX-2,
LOC72841O,
LOC653541,
LOC653548,
LOC653544,
LOC653543,
LOC653545,
LOC440014,
LOC440013,
LOC441056,
LOC728022,
DUX4,
LOC652119,
LOC440017
LOC727961
LOC100128019
LOC 100129894
LOC100131043
LOC100288869
UNQ5830
FLJ34223
LOC645895
LOC645967
LOC648149
LOC727799
MIR548B
IGHD20R152B

IGHJ@

IGHJ@

653541

LOC653541

protein-coding

Not on current assembly

-

727961
100128019
100129894
100131043
100288869
400943
440479
645895
645967
648149
727799
693128

LOC727961
LOClO0128019
LOClO0129894
LOC100131043
LOC 100288869
LOC400943
FLJ34223
LOC645895
LOC645967
LOC648149
LOC727799
MIR548B

protein-coding
unknown
unknown
unknown
unknown
unknown
unknown
unknown
unknown
unknown
unknown
miscRNA

Not
Not
Not
Not
Not
Not
Not
Not
Not
Not
Not
Not

-

28332

IGHD20R152B
IGHJ@

other

Not annot. on reference assembly

other

Not annot. on reference assembly

......

....
I'-'

3506

on current assembly
on current assembly
on current assembly
on current assembly
on current assembly
on current assembly
on current assembly
on current assembly
on current assembly
on current assembly
on current assembly
annot. on reference assembly

DAVID

-

-

MAD Gene

LOC653541

hCG_1776047
LOClOO128019
LOC100129894
LOC 100 131043
LOC 100288869
UNQ5830
FLJ34223
LOC645895
LOC645967
LOC648149
LOC727799
MIR548B
IGHD20R152B

IGHJ@
Continued on next page ...

Entrez ID

>-'

h:)

en

100313795
100313815
28301
28854
28861
4699
654813
100189517
25784
3405
4375
554188
594832
6893
7889
882
89760
100302562
400579
286009
387281
402469
26101
283911
55547
653486
100133452
100292981
100294336
647349
'-----

-

Gene symbol
(NCBI)
PIRC73
PIRC54
IGRV30R16-15
IGKV30R2-5
IGKV20R2-1
NDUFA5P1
P2RYlOP1
TRNAN35
DGCR12
IDDM6
MRX11
FCMTE2
MYPll
TAPVR1
PSORS3
CCAL1
MRX75
MENAQ2
FLJ35934
LOC286009
LCRB
LOC402469
DKFZP564M146
LOC283911
RAB1
LOC653486
LOC100133452
LOC100292981
LOC100294336
LOC647349
--

--

-

Table A.2 - continued from previous page
Gene
type
NCBI annotation
HMS & ID
(NCBI)
other
Not annot. on reference assembly
PIRC73
other
Not annot. on reference assembly
PIRC54
pseudo
Not annot. on reference assembly
IGRV30R16-15
pseudo
Not annot. on reference assembly
IGKV30R2-5
pseudo
Not annot. on reference assembly
IGKV20R2-1
pseudo
Not annot. on reference assembly
NDUFA5P1
pseudo
Not annot. on reference assembly
P2RY10P1
tRNA
Not annot. on reference assembly
TRNAN35
unknown
Not annot. on reference assembly
DGCR12
unknown
Not annot. on reference assembly
IDDM6
unknown
Not annot. on reference assembly
MRX11
unknown
Not annot. on reference assembly
FCMTE2
unknown
Not annot. on reference assembly
MYPll
unknown
Not annot. on reference assembly
TAPVRI
unknown
Not annot. on reference assembly
PSORS3
unknown
Not annot. on reference assembly
CCAL1
unknown
Not annot. on reference assembly
MRX75
unknown
Not annot. on reference assembly
miscRNA
Not annot. on reference assembly
other
Not annot. on reference assembly
other
Not annot. on reference assembly
other
Not annot. on reference assembly
protein-coding
Not annot. on reference assembly
protein-coding
Not annot. on reference assembly
protein-coding
Not annot. on reference assembly
protein-coding
Not annot. on reference assembly
pseudo
Not annot. on reference assembly
pseudo
Not annot. on reference assembly
pseudo
Not annot. on reference assembly
pseudo
Not annot. on reference assembly
-----

DAVID

MAD Gene

-

-

-

-

IGRV30R16-15
IGKV30R2-5
IGKV20R2-1
NDUFA5P1
P2RYlOP1
TRNAN35P
DGCR12
IDDM6
MRXll
FCMTE2
MYP11
TAPVR1
PSORS3
CCALI
MRX75

IGRV30R16-15
IGKV30R2-5
IGKV20R2-1
NDUFA5P1
P2RYlOP1
TRNAN35P
DGCR12
IDDM6
MRXll
FCMTE2
MYPll
TAPVR1
PSORS3
CCAL1
MRX75
MENAQ2
FLJ35934
tcag7.929
LCRB
tcag7.1056

I

I

-

i
I

!

.

.

FLJ35934
LOC286009
LCRB
LOC402469
DKFZP564M146 DKFZP564M146~
LOC283911
LOC283911
RAB1
RAB1
hCG_1741344
LOC653486
LOC100133452
LOC100133452
LOC100292981
LOC100292981
LOC100294336
LOC100294336
LOC647349
LOC647349
Continued on next page ...

Entrez ID

>-'
t-:l

O'l

652073
730535
100049541
100134822
100188748
100188844
100188852
100188853
100190985
100271922
100293044
338030
414058
474225
474261
474285
474294
474295
50989
544599
544616
780911
780925
7834
8008
8041
8173
8205

Gene symbol
(NCBI)
LOC652073
LOC730535
STUT1
LOC100134822
STHAG5
MAFD6
SHEP8
BMND7
IS5
BFIC4
LOC100293044
GLM1
ACRPV
RA5
BP15
OA1
BW19
BW20
HMSNO
AASTH45
COHEN2
TQDS
CHMRQ
PCAP
BDMF
TP250
CNSN
TAM

Table A.2 - continued from previous page
Gene
type
NCBI annotation
HMS & ID
(NCBI)
Not annot. on reference assembly
pseudo
Not annot. on reference assembly
pseudo
Not annot. on reference assembly
unknown
Not annot. on reference assembly
unknown
unknown
Not annot. on reference assembly
Not annot. on reference assembly
unknown
unknown
Not annot. on reference assembly
Not annot. on reference assembly
unknown
Not annot. on reference assembly
unknown
unknown
Not annot. on reference assembly
Not annot. on reference assembly
unknown
unknown
Not annot. on reference assembly
Not annot. on reference assembly
unknown
Not annot. on reference assembly
unknown
Not annot. on reference assembly
unknown
unknown
Not annot. on reference assembly
Not annot. on reference assembly
unknown
unknown
Not annot. on reference assembly
Not annot. on reference assembly
unknown
unknown
Not annot. on reference assembly
Not annot. on reference assembly
unknown
Not annot. on reference assembly
unknown
Not annot. on reference assembly
unknown
Not annot. on reference assembly
unknown
unknown
Not annot. on reference assembly
Not annot. on reference assembly
unknown
unknown
Not annot. on reference assembly
Not annot. on reference assembly
unknown
-

-

DAVID

MAD Gene

LOC652073
LOC730535
STUT1
LOC100134822
STHAG5
MAFD6
SHEP8
BMND7
IS5
BFIC4
LOC100293044
GLM1
ACRPV
RA5
BP15
OA1
BW19
BW20
HMSNO
AASTH45
COHEN2
TQDS
CHMRQ
PCAP
BDMF
TP250
CNSN
TAM

LOC652073
LOC730535
STUTl
LOC100134822
STHAG5
MAFD6
SHEP8
BMND7
IS5
BFIC4
LOC100293044
GLM1
ACRPV
RA5
BP15
GPR143
BW19
BW20
HMSNO
AASTH45
COHEN2
TQDS
CHMRQ
PCAP
BDMF
TP250
CNSN
TAM

,

A.2

Entrez IDs converted to RefSeq

Table A.3: Entrez IDs converted to Refseq by MADGene missed by AbsIDConvert.

EntrezID

RefSeq (NCBI)

DAVID
NR_004406,
NR_002907,

MAD Gene

6080

NR_002907

NR_002907

26822

NR_000022

NR_000022

100302146
100302193
100302167

NR_031634
NR_031656
NR_031629

NR_031634
NR_031656
NR_031629

NR_004385,
NR_004404,
NR_004386
NR_001452,
NR_001453,
NR_000022

Onto-Translate
NR_002907

NR_001454,
NR_003125,

NR_000022

-

-

-

-

NR_031629

-

Table A.4: Genomic intervals found by AbsIDconvert for the five unmapped Entrez IDs found by
MADGene.
Entrez ID
6080
26822
100302146
100302193
100302167

chromosome
chrl
chr11
chr20
chr4
chr9

start
28833877
17096200
49231173
102251459
69002239

127

end
28834083
17096291
49231322
102251571
69002321

width
207
92
150
113
83

strand

+
-

-

Table A.5: Entrez IDs to RefSeq conversion by DAVID, with missing annotation from NCB!.

EntrezID
100129552
285176
388474
440991
642538
642585
644634
646050
653252
727828
727984
728513
728533
728698
728953
728970
729163
729458
729992
81458

DAVID
NM_001029
NM_006013, NR_026898
NM_000972
NM_001005
NM_006333, NM_173177
NM_003374
NR_027002
NM_022831
NM_006327
NM_OO 1164397
NM_001035006, NM_000985
NM_032882
NM_014761
NM_001416, NR_002912
NM_001022
NM_025113
NM_001444
NM_144614
NM_003932
NM_001001824

NCBI Entrez annotation for DAVID RefSeq
6231
6134
6130
6188
10438
7416
388692
64853
100287932
642446
6139, 6140
84968
9798
1973
6223
80183
2171
125997
6767
403239
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Table A.6: Entrez IDs converted to RefSeq IDs exclusively by AbsIDconvert.
EntrezID
81104
100505905
400433
100131381
100652874
100463488
100271846
642612
100507421
100287466
100313837
100329109
647135
100422851
100422860
284648
100289373
100500878
100506548
100359394
100507582
100505687
554206
729444
100129464
253962
147093
284865
100507401
100506241
100616164
100616469
100616499
100616399
100616315
284395
81343
440519

RefSeq
-

NM_001190708
NM_001l91055
NM_001195234
NM_001195278
NM_001242319
NR_031576
NR_033248
NR_034178
NR_036200
NR_036251
NR_036490
NR_036531, NR_o:I6532
NR_037450
NR_037665
NR_037842
NR_037903
NR_038301, NR_038302
NR_038379
NR_038388
NR_038428
NR_038439
NR_038442
NR_038460
NR_038909
NR_038954
NR_039616
NR_039627
NR_039634
NR_039635
NR_039942
NR_040029
NR_045005
NR_045525

AbsIDconvert
NR_015416
NM_001256876, NM_001256877
NR_033787
NR_029697
NR_046251, NR_046252, NR_046253, NR_046254, NR_046255
NI\LOO 11 !)0708
NM_001191055
NM_001l95234
NM_001195278
NM_001242319, Nl\L032882
NR_031576
NR_033248
NR_034178
NR_036200
NR_036251
NR_036490
NR_036531. NR_036532
NR_037450
NR_037665
NR_037842
NR_037903
NR_038301, NR_038302
NR_038379
NR_038388
NR_038428
NR_038439
NR_038442
NR_038460
NR_038909
NR_038954
NR_039616
NR_039627
NR_039634, NR_039636
NR_039635
NR_039942
NR_040029
NR_04500,5
NR_04552.'i
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Table A.7: Genomic intervals for AbsIDconvert Entrez to RefSeq conversion.
chromosome

>-'

CN

o

chr15
chr9
chr9
chr15
chrll
chr3
chr3
chr3
chr3
chr3
chr3
chr3
chr3
chr3
chr3

start

end

width

22332368
540552
540552
85046982
43600529
14961857
14961857
14961857
14961857
14961857
14961857
14961857
14961857
14961857
14961857

22333348
549535
549535
85049663
43606151
14989931
14989931
14989931
14989931
14989931
14989931
14989931
14989931
14989931
14989931

981
8984
8984
2682
5623
28075
28075
28075
28075
28075
28075
28075
28075
28075
28075

strand

+
+
+
+
+
-

-

-

-

name

81104
100505905
100505905
400433
100131381
100652874
100652874
100652874
100652874
100652874
100652874
100652874
100652874
100652874
100652874

chromosome

chr15
chr9
chr9
chr15
chrll
chr3
chr3
chr3
chr3
chr3
chr3
chr3
chr3
chr3
chr3

start

end

22332387
540507
549106
85046594
43602943
14984285
14984285
14984285
14984285
14984285
14988593
14988616
14988620
14989245
14989519

22332775
540666
549720
85050248
43603032
14987660
14987660
14987660
14987660
14987660
14989011
14989011
14989011
14989399
14989947

width

389
160
615
3655
90
3376
3376
3376
3376
3376
419
396
392
155
429

strand

+
+
+
+
+
-

-

name

NR_015416
NM_001256876
NM_001256877
NR_033787
NR_029697
NR_046252
NR_046253
NR_046254
NR_046255
NR_046251
NR_046252
NR_046253
NR_046254
NR_046255
NR_046251

INDEX
AbsIDconvert, 56
accuracy, 74
design, 66
method,65
alternative splicing, 15
annotation, 34
database, 36
functional, 35
nucleotide, 34
process, 36
structural, 34
BLAST,25
BLAT,25
Bowtie,28
cDNA,31
DAVID,60
Deoxyribonucleic Acid, see DNA
DNA,7
replication, 9
EST,30
Eukaryote, 6
exclusion vector, 91
Expressed Sequence Tag, see EST

adenineA,8
cytosineC, 8
guanineG,8
thymineT,8
uracilU, 8
occurrence matrix, 98
occurrence vector, 98
open reading frame, 16
post-transcription, 15
Prokaryote, 6
protein, 11
purine, 8
pyrimidine, 8
red-black tree, 47
rRNA,18
small molecules, 7
transcription, 12, 14
translation, 12
tRNA,18
untranslated region, see UTR
UTR,19

gene, 13
genome, 19
alignment, 24
assembly, 24
sequencing, 20
granularity, 58
interval, 43
overlap, 46
interval-tree, 48
messenger RNA, see mRNA
microarray, 31
microRN A, see miRN A
miRNA, 11
mRNA,lO
nucleotide, 8
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